FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Olle Ringdén

Research Profile

Disorders

Procedures

Living Beings

Concepts & Ideas

Phenomena

Recurrence

Anatomy

T-Lymphocytes

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Olle Ringdén; Mehmet Uzunel; Magnus Westgren; Jonas Mattsson; Silvia Nava; Réka Conrad; Tom Erkers; E Iwarsson; Helen Kaipe
Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host disease.
Olle Ringdén; Petter Svenberg; Marie Wikström; Charlotta Edeskog; Britta Eriksson; Sigrun Finnbogadottir; Karin Fransson; Katarina Holmberg; Jonas Mattsson; Ruza Milovsavljevic; Brigitta Omazic; Mats Remberger; Britt-Marie Svahn
Many days at home during neutropenia after allogeneic hematopoietic stem cell transplantation correlates with low incidence of acute graft-versus-host disease.
Mats Remberger; Olle Ringdén
Treatment of severe acute graft-versus-host disease with mesenchymal stromal cells: a comparison with non-MSC treated patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Olle Ringdén (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Olle Ringdén; Mehmet Uzunel; Magnus Westgren; Jonas Mattsson; Silvia Nava; Réka Conrad; Tom Erkers; E Iwarsson; Helen Kaipe
Fetal membrane cells for treatment of steroid-refractory acute graft-versus-host disease.
Stem cells (Dayton, Ohio) 2013;31(3):592-601.
2013: Olle Ringdén; Petter Svenberg; Marie Wikström; Charlotta Edeskog; Britta Eriksson; Sigrun Finnbogadottir; Karin Fransson; Katarina Holmberg; Jonas Mattsson; Ruza Milovsavljevic; Brigitta Omazic; Mats Remberger; Britt-Marie Svahn
Many days at home during neutropenia after allogeneic hematopoietic stem cell transplantation correlates with low incidence of acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2013;19(2):314-20.
2012: Mats Remberger; Olle Ringdén
Treatment of severe acute graft-versus-host disease with mesenchymal stromal cells: a comparison with non-MSC treated patients.
International journal of hematology 2012;96(6):822-4.
2012: Sofia Berglund; Jens Gertow; Katarina Le Blanc; Per Ljungman; Mats Remberger; Olle Ringdén; Petter Svenberg; Michael Uhlin; Mehmet Uzunel; Jacek Winiarski; Jonas Mattsson
Factors with an impact on chimerism development and long-term survival after umbilical cord blood transplantation.
Transplantation 2012;94(10):1066-74.
2012: Olle Ringdén; Behnam Sadeghi
Is graft-versus-leukemia more effective using reduced-intensity conditioning compared with myeloablative conditioning?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(11):1615-7.
2012: Ulrica Forslöw; Britt Gustafsson; Katarina LeBlanc; Jonas Mattsson; Ola Blennow; Olle Ringdén; Mats Remberger
Treatment with mesenchymal stromal cells is a risk factor for pneumonia-related death after allogeneic hematopoietic stem cell transplantation.
European journal of haematology 2012;89(3):220-7.
2012: Guido Moll; Bo Nilsson; Kristina Nilsson-Ekdahl; Ida Rasmusson-Duprez; Olle Ringdén; Javier Sanchez; Yuji Teramura; Lena von Bahr; Anne-Marie Connolly-Andersen; Graciela Elgue; Lillemor Funke; Osama A Hamad; Olle Korsgren; Helena Lönnies; Peetra U Magnusson; Katarina Le Blanc
Are therapeutic human mesenchymal stromal cells compatible with human blood?
Stem cells (Dayton, Ohio) 2012;30(7):1565-74.
2012: Olle Ringdén; H Schouten; S Shrestha; M-J Zhang; G T da Silva; A Dispenzieri; Cesar O Freytes; R P Gale; J Gibson; V Gupta; L Holmberg; R Kamble; H Lazarus; Sagar Lonial; P McCarthy; K Meehan; G A Milone; Mats Remberger; P N Hari
Effect of acute and chronic GVHD on relapse and survival after reduced-intensity conditioning allogeneic transplantation for myeloma.
Bone marrow transplantation 2012;47(6):831-7.
2012: Britt-Marie Svahn; O Alvin; H Karlsson; Mats Remberger; Olle Ringdén
Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation.
Bone marrow transplantation 2012;47(5):706-15.
2012: Olle Ringdén; Gerard Socie; Giovanni F Torelli; Liisa Volin; Arturo I Atienza; Michel Attal; Catherine Cordonnier; Norbert-Claude Gorin; Olivier Hermine; Jean P Jouet; Myriam Labopin; Mauricette Michallet; Noel Milpied; Mohamad Mohty
Growth factor-associated graft-versus-host disease and mortality 10 years after allogeneic bone marrow transplantation.
British journal of haematology 2012;157(2):220-9.
2012: Lena von Bahr; Birgitta Sander; Berit Sundberg; Britt Gustafsson; Hans Hägglund; Holger Karbach; Helen Karlsson; Katarina Le Blanc; Per Ljungman; Lena Lönnies; Olle Ringdén
Long-term complications, immunologic effects, and role of passage for outcome in mesenchymal stromal cell therapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2012;18(4):557-64.
2011: Olle Ringdén; Petter Svenberg; Michael Uhlin; Mehmet Uzunel; Göran Dahllöf; Karin Garming-Legert; Helen Karlsson; Mats Remberger; Jonas Mattsson
Sirolimus and tacrolimus as immune prophylaxis compared to cyclosporine with or without methotrexate in patients undergoing allogeneic haematopoietic stem cell transplantation for non-malignant disorders.
European journal of haematology 2011;87(6):503-9.
2011: Sherif S Farag; Stephen L George; Luis Isola; Richard A Larson; Hillard M Lazarus; Mark R Litzow; Kati Maharry; Guido Marcucci; David I Marks; Krzysztof Mrózek; Waleska S Pérez; Olle Ringdén; David A Rizzieri; Robert Soiffer; Martin S Tallman; Daniel J Weisdorf; Mei-Jie Zhang; Maria R Baer; Clara D Bloomfield; Donald W Bunjes; Mitchell S Cairo; Edward Copelan; Corey Cutler; John DiPersio
Comparison of reduced-intensity hematopoietic cell transplantation with chemotherapy in patients age 60-70 years with acute myelogenous leukemia in first remission.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(12):1796-803.
2011: Göran Dahllöf; Karin Garming-Legert; Mats Remberger; Monica Barr Agholme; Biniyam Wondimu; Olle Ringdén
Xerostomia in children and adolescents after stem cell transplantation conditioned with total body irradiation or busulfan.
Oral oncology 2011;47(9):915-9.
2011: Anna Nordlander; Olle Ringdén; Michael Uhlin; Dan Hauzenberger; Gunilla Kumlien; Jonas Mattsson
Immune modulation to prevent antibody-mediated rejection after allogeneic hematopoietic stem cell transplantation.
Transplant immunology 2011;25(2-3):153-8.
2011: David Valcárcel; Jorge Sierra; Tao Wang; Fangyu Kan; Vikas Gupta; gregory alan hale; David I Marks; Philip L McCarthy; Machteld Oudshoorn; Effie W Petersdorf; Olle Ringdén; Michelle Setterholm; Stephen R Spellman; Edmund K Waller; James L Gajewski; Susana R Marino; David Senitzer; Stephanie J Lee
One-antigen mismatched related versus HLA-matched unrelated donor hematopoietic stem cell transplantation in adults with acute leukemia: Center for International Blood and Marrow Transplant Research results in the era of molecular HLA typing.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2011;17(5):640-8.
2011: Helen Karlsson; Silvia Nava; Mats Remberger; Zuzana Hassan; Moustapha Hassan; Olle Ringdén
N-acetyl-L-cysteine increases acute graft-versus-host disease and promotes T-cell-mediated immunity in vitro.
European journal of immunology 2011;41(4):1143-53.
2011: Guido Moll; Dimitrios Mougiakakos; Graciela Elgue; Regina Jitschin; John D Lambris; Katarina Le Blanc; Lena Lönnies; Kristina Nilsson-Ekdahl; Ida Rasmusson-Duprez; Olle Ringdén; Berit Sundberg; Lena von Bahr; Bo Nilsson
Mesenchymal stromal cells engage complement and complement receptor bearing innate effector cells to modulate immune responses.
PloS one 2011;6(7):e21703.
2011: Mats Remberger; Jonas Mattsson; Richard Olsson; Olle Ringdén
Second allogeneic hematopoietic stem cell transplantation: a treatment for graft failure.
Clinical transplantation 2011;25(1):E68-76.
2010: Darius Sairafi; Mats Remberger; Michael Uhlin; Per Ljungman; Olle Ringdén; Jonas Mattsson
Leukemia lineage-specific chimerism analysis and molecular monitoring improve outcome of donor lymphocyte infusions.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2010;16(12):1728-37.
2010: Andreas T Björklund; Marie Schaffer; Cyril Fauriat; Olle Ringdén; Mats Remberger; Christina Hammarstedt; A John Barrett; Per Ljungman; Hans-Gustaf Ljunggren; Karl-Johan Malmberg
NK cells expressing inhibitory KIR for non-self-ligands remain tolerant in HLA-matched sibling stem cell transplantation.
Blood 2010;115(13):2686-94.
2010: Richard Olsson; Mats Remberger; Zuzana Hassan; Brigitta Omazic; Jonas Mattsson; Olle Ringdén
GVHD prophylaxis using low-dose cyclosporine improves survival in leukaemic recipients of HLA-identical sibling transplants.
European journal of haematology 2010;84(4):323-31.
2010: Jonas Mattsson; A Nordlander; Mats Remberger; Michael Uhlin; J Holgersson; Olle Ringdén; D Hauzenberger
Cytotoxic crossmatch analysis before allo-SCT is a poor diagnostic tool for prediction of rejection.
Bone marrow transplantation 2010;45(2):235-8.
2009: Olle Ringdén; Helen Karlsson; Richard Olsson; Brigitta Omazic; Michael Uhlin
The allogeneic graft-versus-cancer effect.
British journal of haematology 2009;147(5):614-33.
2009: Petter Svenberg; Jonas Mattsson; Olle Ringdén; Mehmet Uzunel
Allogeneic hematopoietic SCT in patients with non-malignant diseases, and importance of chimerism.
Bone marrow transplantation 2009;44(11):757-63.
2009: Olle Ringdén
Mesenchymal stromal cells as first-line treatment of graft failure after hematopoietic stem cell transplantation.
Stem cells and development 2009;18(9):1243-6.
2009: David I Marks; Karen Ballen; Brent R Logan; Zhiwei Wang; Kathleen A Sobocinski; Andrea Bacigalupo; Linda J Burns; Vikas Gupta; Vincent Ho; Philip L McCarthy; Olle Ringdén; Harry C Schouten; Matthew Seftel; J Douglas Rizzo
The effect of smoking on allogeneic transplant outcomes.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(10):1277-87.
2009: H Omar; Hans Hägglund; Asa Gustafsson-Jernberg; K LeBlanc; Jonas Mattsson; Mats Remberger; Olle Ringdén; Elda Sparrelid; M Sundin; Jacek Winiarski; Z Yun; Per Ljungman
Targeted monitoring of patients at high risk of post-transplant lymphoproliferative disease by quantitative Epstein-Barr virus polymerase chain reaction.
Transplant infectious disease : an official journal of the Transplantation Society 2009;11(5):393-9.
2009: Olle Ringdén; Myriam Labopin; Gerhard Ehninger; Dietger Niederwieser; Richard Olsson; Nadezda Basara; Juergen Finke; Rainer Schwerdtfeger; Matthias Eder; Donald Bunjes; Norbert-Claude Gorin; Mohamad Mohty; Vanderson Rocha
Reduced intensity conditioning compared with myeloablative conditioning using unrelated donor transplants in patients with acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(27):4570-7.
2009: Lisbeth Barkholt; Evren Alici; Reka Conrad; Tolga Sutlu; Mari Gilljam; B Stellan; Birger Christensson; Hayrettin Guven; Niklas K Björkström; Gunnar Söderdahl; Kerstin Cederlund; Eva Kimby; Johan Aschan; Olle Ringdén; Hans-Gustaf Ljunggren; M Sirac Dilber
Safety analysis of ex vivo-expanded NK and NK-like T cells administered to cancer patients: a phase I clinical study.
Immunotherapy 2009;1(5):753-64.
2009: Katarina Le Blanc; A John Barrett; Marie Schaffer; Hans Hägglund; Per Ljungman; Olle Ringdén; Mats Remberger
Lymphocyte recovery is a major determinant of outcome after matched unrelated myeloablative transplantation for myelogenous malignancies.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(9):1108-15.
2009: Mikael Sundin; A John Barrett; Olle Ringdén; Mehmet Uzunel; Helena Lönnies; Asa-Lena Dackland; Birger Christensson; Katarina Le Blanc
HSCT recipients have specific tolerance to MSC but not to the MSC donor.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2009;32(7):755-64.
2009: Olle Ringdén; Helen Karlsson; Brigitta Omazic
Immune reconstitution after HLA mismatched haemopoietic stem-cell transplantation.
The lancet oncology 2009;10(5):440-2.
2009: Christian Benden; Anne I Dipchand; Lara A Danziger-Isakov; Carlos O Esquivel; Olle Ringdén; Jo Wray; Stephen D Marks
Pediatric transplantation: ten years on.
Pediatric transplantation 2009;13(3):272-7.
2009: Massimo Aglietta; Lisbeth Barkholt; Fabrizio Carnevale Schianca; Daniela Caravelli; Brigitta Omazic; Coludia Minotto; Francesco Leone; Patrik Hentschke; Giovanni Bertoldero; Antonio Capaldi; Giovannino Ciccone; Dietger Niederwieser; Olle Ringdén; Tanner Demirer
Reduced-intensity allogeneic hematopoietic stem cell transplantation in metastatic colorectal cancer as a novel adoptive cell therapy approach. The European group for blood and marrow transplantation experience.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(3):326-35.
2009: Michael Uhlin; Mantas Okas; Helen Karlsson; Jens Gertow; Lars Henningsohn; Olle Ringdén; Klas Kärre; Victor Levitsky; Jonas Mattsson
Increased frequency and responsiveness of PSA-specific T cells after allogeneic hematopoetic stem-cell transplantation.
Transplantation 2009;87(4):467-72.
2009: H Samuelsson; Olle Ringdén; Helena Lönnies; Katarina Le Blanc
Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells.
Cytotherapy 2009;11(2):129-36.
2008: Gunilla Malm; Ulrika von Döbeln; Karin Naess; Olle Ringdén
[Progress on lysosomal diseases yields hope for cure and improvement].
Läkartidningen 2008;105(51-52):3731-5.
2008: Theresa Hahn; Philip L McCarthy; Mei-Jie Zhang; Dan Wang; Mukta Arora; Haydar Frangoul; Robert Peter Gale; gregory alan hale; John Horan; Luis Isola; Richard T Maziarz; Jon van Rood; Vikas Gupta; Joerg Halter; Vijay Reddy; Pierre Tiberghien; Mark Litzow; Claudio Anasetti; Stephen Pavletic; Olle Ringdén
Risk factors for acute graft-versus-host disease after human leukocyte antigen-identical sibling transplants for adults with leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5728-34.
2008: Dan Hauzenberger; M Schaffer; Olle Ringdén; Zuzana Hassan; Brigitta Omazic; Jonas Mattsson; A-C Wikström; Mats Remberger
Outcome of haematopoietic stem cell transplantation in patients transplanted with matched unrelated donors vs allele-mismatched donors: a single centre study.
Tissue antigens 2008;72(6):549-58.
2008: Olle Ringdén; M Okas; Michael Uhlin; Mehmet Uzunel; Mats Remberger; Jonas Mattsson
Unrelated cord blood and mismatched unrelated volunteer donor transplants, two alternatives in patients who lack an HLA-identical donor.
Bone marrow transplantation 2008;42(10):643-8.
2008: Gunilla Malm; Britt Gustafsson; Gunilla Berglund; Maria Lindström; Karin Naess; Birgit Borgström; Ulrika von Döbeln; Olle Ringdén
Outcome in six children with mucopolysaccharidosis type IH, Hurler syndrome, after haematopoietic stem cell transplantation (HSCT).
Acta paediatrica (Oslo, Norway : 1992) 2008;97(8):1108-12.
2008: Helen Karlsson; Sujith Samarasinghe; Lynne M Ball; Berit Sundberg; Arjan C Lankester; Francesco Dazzi; Mehmet Uzunel; Kanchan Rao; Paul Veys; Katarina Le Blanc; Olle Ringdén; Persis J Amrolia
Mesenchymal stem cells exert differential effects on alloantigen and virus-specific T-cell responses.
Blood 2008;112(3):532-41.
2008: D Sairafi; M Uzunel; Mats Remberger; Olle Ringdén; Jonas Mattsson
No impact of NOD2/CARD15 on outcome after SCT.
Bone marrow transplantation 2008;41(11):961-4.
2008: Katarina Le Blanc; Francesco Frassoni; Lynne Ball; Franco Locatelli; Helene Roelofs; Ian Lewis; Edoardo Lanino; Berit Sundberg; Maria Ester Bernardo; Mats Remberger; Giorgio Dini; R Maarten Egeler; Andrea Bacigalupo; Willem Fibbe; Olle Ringdén
Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study.
Lancet 2008;371(9624):1579-86.
2008: Benjamin Edvinsson; Jessica Lundquist; Per Ljungman; Olle Ringdén; Birgitta Evengård
A prospective study of diagnosis of Toxoplasma gondii infection after bone marrow transplantation.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2008;116(5):345-51.
2008: Mats Remberger; Jonas Mattsson; Dan Hausenberger; Marie Schaffer; Britt-Marie Svahn; Olle Ringdén
Genomic tissue typing and optimal antithymocyte globuline dose using unrelated donors results in similar survival and relapse as HLA-identical siblings in haematopoietic stem-cell transplantation for leukaemia.
European journal of haematology 2008;80(5):419-28.
2008: Lisbeth Barkholt; Mats Remberger; Zuzana Hassan; K Fransson; Brigitta Omazic; Britt-Marie Svahn; H Karlsson; M Brune; Moustapha Hassan; Jonas Mattsson; Olle Ringdén
A prospective randomized study using N-acetyl-L-cysteine for early liver toxicity after allogeneic hematopoietic stem cell transplantation.
Bone marrow transplantation 2008;41(9):785-90.
2008: Britt-Marie Svahn; Mats Remberger; Mona Heijbel; Eva Martell; Marie Wikström; Britta Eriksson; Ruza Milovsavljevic; Jonas Mattsson; Olle Ringdén
Case-control comparison of at-home and hospital care for allogeneic hematopoietic stem-cell transplantation: the role of oral nutrition.
Transplantation 2008;85(7):1000-7.
2008: Réka Conrad; Mats Remberger; Kerstin Cederlund; Olle Ringdén; Lisbeth Barkholt
A comparison between low intensity and reduced intensity conditioning in allogeneic hematopoietic stem cell transplantation for solid tumors.
Haematologica 2008;93(2):265-72.
2008: A-C Norlin; D Sairafi; Jonas Mattsson; Per Ljungman; Olle Ringdén; Mats Remberger
Allogeneic stem cell transplantation: low immunoglobulin levels associated with decreased survival.
Bone marrow transplantation 2008;41(3):267-73.
2008: Mats Remberger; Jonas Mattsson; Zuzana Hassan; N Karlsson; K LeBlanc; Brigitta Omazic; M Okas; D Sairafi; Olle Ringdén
Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study.
Bone marrow transplantation 2008;41(4):399-405.
2008: Mikael Sundin; M Remberger; H Lönnies; Berit Sundberg; Olle Ringdén; Katarina Le Blanc
No increased trapping of multipotent mesenchymal stromal cells in bone marrow filters compared with other bone marrow cells.
Cytotherapy 2008;10(3):238-42.
2008: Jonas Mattsson; Olle Ringdén; Rainer Storb
Graft failure after allogeneic hematopoietic cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2008;14(1 Suppl 1):165-70.
2007: Bronwen E Shaw; Theodore A Gooley; Mari Malkki; J Alejandro Madrigal; Ann B Begovich; Mary M Horowitz; Alois Gratwohl; Olle Ringdén; Steven G E Marsh; Effie W Petersdorf
The importance of HLA-DPB1 in unrelated donor hematopoietic cell transplantation.
Blood 2007;110(13):4560-6.
2007: Katarina Le Blanc; Olle Ringdén
Immunomodulation by mesenchymal stem cells and clinical experience.
Journal of internal medicine 2007;262(5):509-25.
2007: Gayane Avetisyan; Johan Aschan; Hans Hägglund; Olle Ringdén; Per Ljungman
Evaluation of intervention strategy based on CMV-specific immune responses after allogeneic SCT.
Bone marrow transplantation 2007;40(9):865-9.
2007: Anna Januszkiewicz; Maria Klaude; Karin Loré; Jan Andersson; Olle Ringdén; Olav Rooyackers; Jan Wernerman
Enhanced in vivo protein synthesis in circulating immune cells of ICU patients.
Journal of clinical immunology 2007;27(6):589-97.
2007: Olle Ringdén; Mehmet Uzunel; Berit Sundberg; L Lönnies; S Nava; J Gustafsson; L Henningsohn; Katarina Le Blanc
Tissue repair using allogeneic mesenchymal stem cells for hemorrhagic cystitis, pneumomediastinum and perforated colon.
Leukemia 2007;21(11):2271-6.
2007: Katarina Le Blanc; Håkan Samuelsson; Lena Lönnies; Mikael Sundin; Olle Ringdén
Generation of immunosuppressive mesenchymal stem cells in allogeneic human serum.
Transplantation 2007;84(8):1055-9.
2007: Lisbeth Barkholt; Mats Remberger; H Bodegård; Olle Ringdén; Y Böttiger
Cyclosporine A (CsA) 2-h concentrations vary between patients without correlation to graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
Bone marrow transplantation 2007;40(7):683-9.
2007: Zuzana Hassan; Mats Remberger; Petter Svenberg; Maria Elbander; Brigitta Omazic; Jonas Mattsson; Réka Conrad; Britt-Marie Svahn; Anders Ahlgren; Darius Sairafi; Johan Aschan; Katarina Le Blanc; Lisbeth Barkholt; Olle Ringdén
Hemorrhagic cystitis: a retrospective single-center survey.
Clinical transplantation 2007;21(5):659-67.
2007: Mikael Sundin; Olle Ringdén; Berit Sundberg; Silvia Nava; Cecilia Götherström; Katarina Le Blanc
No alloantibodies against mesenchymal stromal cells, but presence of anti-fetal calf serum antibodies, after transplantation in allogeneic hematopoietic stem cell recipients.
Haematologica 2007;92(9):1208-15.
2007: Mats Remberger; Olle Ringdén
Similar outcome after unrelated allogeneic peripheral blood stem cell transplantation compared with bone marrow in children and adolescents.
Transplantation 2007;84(4):551-4.
2007: Katarina Le Blanc; H Samuelsson; B Gustafsson; Mats Remberger; Berit Sundberg; J Arvidson; P Ljungman; Helena Lönnies; S Nava; Olle Ringdén
Transplantation of mesenchymal stem cells to enhance engraftment of hematopoietic stem cells.
Leukemia 2007;21(8):1733-8.
2007: Mats Remberger; Emma Watz; Olle Ringdén; Jonas Mattsson; Agneta Shanwell; Agneta Wikman
Major ABO blood group mismatch increases the risk for graft failure after unrelated donor hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(6):675-82.
2007: Ida Rasmusson; Katarina Le Blanc; Berit Sundberg; Olle Ringdén
Mesenchymal stem cells stimulate antibody secretion in human B cells.
Scandinavian journal of immunology 2007;65(4):336-43.
2007: Olle Ringdén; Mats Remberger; Petter Svenberg; Britt-Marie Svahn; Göran Dahllöf; B Gustafsson; Zuzana Hassan; Brigitta Omazic; Mehmet Uzunel; Johan Aschan; Lisbeth Barkholt; Jacek Winiarski; Per Ljungman; Jonas Mattsson
Fludarabine-based disease-specific conditioning or conventional myeloablative conditioning in hematopoietic stem cell transplantation for treatment of non-malignant diseases.
Bone marrow transplantation 2007;39(7):383-8.
2007: Olle Ringdén
Immunotherapy by allogeneic stem cell transplantation.
Advances in cancer research 2007;97():25-60.
2007: Mats Bågesund; Sven Richter; Olle Ringdén; Göran Dahllöf
Longitudinal scintigraphic study of parotid and submandibular gland function after total body irradiation in children and adolescents.
International journal of paediatric dentistry / the British Paedodontic Society [and] the International Association of Dentistry for Children 2007;17(1):34-40.
2006: Mehmet Uzunel; Mats Remberger; Darius Sairafi; Zuzana Hassan; Jonas Mattsson; Brigitta Omazic; Lisbeth Barkholt; Olle Ringdén
Unrelated versus related allogeneic stem cell transplantation after reduced intensity conditioning.
Transplantation 2006;82(7):913-9.
2006: Katarina Le Blanc; Olle Ringdén
Mesenchymal stem cells: properties and role in clinical bone marrow transplantation.
Current opinion in immunology 2006;18(5):586-91.
2006: Mikael Sundin; Katarina Le Blanc; Olle Ringdén; Lisbeth Barkholt; Brigitta Omazic; Christina Lergin; Victor Levitsky; Mats Remberger
The role of HLA mismatch, splenectomy and recipient Epstein-Barr virus seronegativity as risk factors in post-transplant lymphoproliferative disorder following allogeneic hematopoietic stem cell transplantation.
Haematologica 2006;91(8):1059-67.
2006: Olle Ringdén; Petter Svenberg; Katarina Le Blanc; Jonas Mattsson; Mats Remberger
Myeloablative conditioning for hematopoietic stem-cell transplantation in patients with non-malignant diseases.
Bone marrow transplantation 2006;38(4):321-2.
2006: Britt-Marie Svahn; Ole Alvin; Olle Ringdén; Ann Gardulf; Mats Remberger
Costs of allogeneic hematopoietic stem cell transplantation.
Transplantation 2006;82(2):147-53.
2006: Britt-Marie Svahn; Olle Ringdén; Mats Remberger
Treatment costs and survival in patients with grades III-IV acute graft-versus-host disease after allogenic hematopoietic stem cell transplantation during three decades.
Transplantation 2006;81(11):1600-3.
2006: Olle Ringdén; Katarina Le Blanc
Mesenchymal stem cells combined with cyclosporine inhibits cytotoxic T cells.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(6):693-4.
2006: Mikael Sundin; C Orvell; Ida Rasmusson; Berit Sundberg; Olle Ringdén; Katarina Le Blanc
Mesenchymal stem cells are susceptible to human herpesviruses, but viral DNA cannot be detected in the healthy seropositive individual.
Bone marrow transplantation 2006;37(11):1051-9.
2006: Olle Ringdén; Mehmet Uzunel; Ida Rasmusson; Mats Remberger; Berit Sundberg; Helena Lönnies; Hanns-Ulrich Marschall; Aldona Dlugosz; Attila Szakos; Zuzana Hassan; Brigitta Omazic; Johan Aschan; Lisbeth Barkholt; Katarina Le Blanc
Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease.
Transplantation 2006;81(10):1390-7.
2006: Olle Ringdén; Mats Remberger; Britt-Marie Svahn; Lisbeth Barkholt; Jonas Mattsson; Johan Aschan; Katarina Le Blanc; Britt Gustafsson; Zuzana Hassan; Brigitta Omazic; Petter Svenberg; Göran Solders; Ulrika von Döbeln; Jacek Winiarski; Per Ljungman; Gunilla Malm
Allogeneic hematopoietic stem cell transplantation for inherited disorders: experience in a single center.
Transplantation 2006;81(5):718-25.
2006: Réka Conrad; Mats Remberger; Kerstin Cederlund; Patrik Hentschke; Berit Sundberg; Olle Ringdén; Lisbeth Barkholt
Inflammatory cytokines predominate in cases of tumor regression after hematopoietic stem cell transplantation for solid cancer.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(3):346-54.
2006: Hanna J Khoury; Fausto R Loberiza; Olle Ringdén; A John Barrett; Brian J Bolwell; Jean-Yves Cahn; Richard E Champlin; Robert Peter Gale; gregory alan hale; Alvaro Urbano-Ispizua; Rodrigo Martino; Philip L McCarthy; Pierre Tiberghien; Leo F Verdonck; Mary M Horowitz
Impact of posttransplantation G-CSF on outcomes of allogeneic hematopoietic stem cell transplantation.
Blood 2006;107(4):1712-6.
2006: Per Ljungman; Lena Perez-Bercoff; Jerker Jonsson; Gayane Avetisyan; Elda Sparrelid; Johan Aschan; Lisbeth Barkholt; Kajsa Larsson; Jacek Winiarski; Zhibing Yun; Olle Ringdén
Risk factors for the development of cytomegalovirus disease after allogeneic stem cell transplantation.
Haematologica 2006;91(1):78-83.
2005: Jörg D Seebach; Georg Stussi; Jakob R Passweg; Fausto R Loberiza; James L Gajewski; Armand Keating; Martin Goerner; Philip A Rowlings; Pierre Tiberghien; Gerald J Elfenbein; Robert Peter Gale; Jon van Rood; Vijay Reddy; Eliane Gluckman; Brian J Bolwell; Thomas R Klumpp; Mary M Horowitz; Olle Ringdén; A John Barrett
ABO blood group barrier in allogeneic bone marrow transplantation revisited.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(12):1006-13.
2005: Olle Ringdén; Katarina Le Blanc
Allogeneic hematopoietic stem cell transplantation: state of the art and new perspectives.
APMIS : acta pathologica, microbiologica, et immunologica Scandinavica 2005;113(11-12):813-30.
2005: Britt-Marie Svahn; Olle Ringdén; Mats Remberger
Long-term follow-up of patients treated at home during the pancytopenic phase after allogeneic haematopoietic stem cell transplantation.
Bone marrow transplantation 2005;36(6):511-6.
2005: Steven Z Pavletic; Issa F Khouri; Michael Haagenson; Roberta J King; Philip J Bierman; Michael Bishop; Michael Carston; Sergio Giralt; Arturo Molina; Edward A Copelan; Olle Ringdén; Vivek Roy; Karen K Ballen; Douglas R Adkins; Philip McCarthy; Daniel Weisdorf; Emili Montserrat; Claudio Anasetti
Unrelated donor marrow transplantation for B-cell chronic lymphocytic leukemia after using myeloablative conditioning: results from the Center for International Blood and Marrow Transplant research.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5788-94.
2005: Beatrice Diedrich; Mats Remberger; Agneta Shanwell; Britt-Marie Svahn; Olle Ringdén
A prospective randomized trial of a prophylactic platelet transfusion trigger of 10 x 10(9) per L versus 30 x 10(9) per L in allogeneic hematopoietic progenitor cell transplant recipients.
Transfusion 2005;45(7):1064-72.
2005: Katarina Le Blanc; Cecilia Götherström; Olle Ringdén; Moustapha Hassan; Robert McMahon; Edwin Horwitz; Göran Anneren; Ove Axelsson; Janice Nunn; Uwe Ewald; Solveig Nordén-Lindeberg; Monika Jansson; Ann Dalton; Eva Aström; Magnus Westgren
Fetal mesenchymal stem-cell engraftment in bone after in utero transplantation in a patient with severe osteogenesis imperfecta.
Transplantation 2005;79(11):1607-14.
2005: Katarina Le Blanc; Olle Ringdén
Immunobiology of human mesenchymal stem cells and future use in hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(5):321-34.
2005: Ida Rasmusson; Olle Ringdén; Berit Sundberg; Katarina Le Blanc
Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms.
Experimental cell research 2005;305(1):33-41.
2005: Katarina Le Blanc; Olle Ringdén
Use of mesenchymal stem cells for the prevention of immune complications of hematopoietic stem cell transplantation.
Haematologica 2005;90(4):438.
2005: Patrik Hentschke; Brigitta Omazic; Jonas Mattsson; Ingrid Näsman-Björk; Inger Lundkvist; D Gigliotti; Lisbeth Barkholt; Olle Ringdén; Mats Remberger
T-cell receptor Vbeta repertoire after myeloablative and reduced intensity conditioning allogeneic haematopoietic stem cell transplantation.
Scandinavian journal of immunology 2005;61(3):285-94.
2005: Hakumei Oh; Fausto R Loberiza; Mei-Jie Zhang; Olle Ringdén; Hideki Akiyama; Takayoshi Asai; Shuichi Miyawaki; Shinichiro Okamoto; Mary M Horowitz; Joseph H Antin; Asad Bashey; Jennifer M Bird; Matthew H Carabasi; Joseph W Fay; Robert Peter Gale; Roger H Giller; John M Goldman; gregory alan hale; Richard E Harris; Jean Henslee-Downey; Hans-Jochem Kolb; Mark R Litzow; Philip L McCarthy; Steven M Neudorf; Derek S Serna; Gérard Socié; Pierre Tiberghien; A John Barrett
Comparison of graft-versus-host-disease and survival after HLA-identical sibling bone marrow transplantation in ethnic populations.
Blood 2005;105(4):1408-16.
2005: Olle Ringdén
Introduction to graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(2 Suppl 2):17-20.
2005: Karl-Johan Malmberg; Marie Schaffer; Olle Ringdén; Mats Remberger; Hans-Gustaf Ljunggren
KIR-ligand mismatch in allogeneic hematopoietic stem cell transplantation.
Molecular immunology 2005;42(4):531-4.
2005: Anna Januszkiewicz; Maria Klaude; Karin Loré; Jan Andersson; Olle Ringdén; Olav Rooyackers; Jan Wernerman
Determination of in vivo protein synthesis in human palatine tonsil.
Clinical science (London, England : 1979) 2005;108(2):179-84.
2005: Mats Remberger; Dietrich W Beelen; Axel A Fauser; Nadezda Basara; Oliver Basu; Olle Ringdén
Increased risk of extensive chronic graft-versus-host disease after allogeneic peripheral blood stem cell transplantation using unrelated donors.
Blood 2005;105(2):548-51.
2005: Albert N Békássy; Olle Ringdén; Gunnar Juliusson; Jacek Winiarski
[Collection of fetal blood should be publicly financed].
Läkartidningen 2005;102(1-2):64.
2005: Brigitta Omazic; Patrik Hentschke; Ingrid Näsman-Björk; Jonas Mattsson; V-A Oxelius; Olle Ringdén; Lisbeth Barkholt; Johan Permert; Inger Lundkvist
Reconstitution of the Ig heavy chain CDR3 repertoire after allogeneic haematopoietic stem cell transplantation with myeloablative or reduced-intensity conditioning regimens.
Scandinavian journal of immunology 2005;61(1):72-81.
2004: Mary Eapen; Mary M Horowitz; John P Klein; Richard E Champlin; Fausto R Loberiza; Olle Ringdén; John E Wagner
Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: the Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(24):4872-80.
2004: Petter Svenberg; Mats Remberger; Johan Svennilson; Jonas Mattsson; Katarina Leblanc; Britt Gustafsson; Johan Aschan; Lisbeth Barkholt; Jacek Winiarski; Per Ljungman; Olle Ringdén
Allogenic stem cell transplantation for nonmalignant disorders using matched unrelated donors.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(12):877-82.
2004: Per Ljungman; Johan Aschan; B Gustafsson; Ilona Lewensohn-Fuchs; Jacek Winiarski; Olle Ringdén
Long-term immunity to poliovirus after vaccination of allogeneic stem cell transplant recipients.
Bone marrow transplantation 2004;34(12):1067-9.
2004: Marie Schaffer; Karl-Johan Malmberg; Olle Ringdén; Hans-Gustaf Ljunggren; Mats Remberger
Increased infection-related mortality in KIR-ligand-mismatched unrelated allogeneic hematopoietic stem-cell transplantation.
Transplantation 2004;78(7):1081-5.
2004: Katarina Le Blanc; Mats Remberger; Mehmet Uzunel; Jonas Mattsson; Lisbeth Barkholt; Olle Ringdén
A comparison of nonmyeloablative and reduced-intensity conditioning for allogeneic stem-cell transplantation.
Transplantation 2004;78(7):1014-20.
2004: Asa Gustafsson-Jernberg; Mats Remberger; Olle Ringdén; Jacek Winiarski
Risk factors in pediatric stem cell transplantation for leukemia.
Pediatric transplantation 2004;8(5):464-74.
2004: Mary Eapen; Sergio Giralt; Mary M Horowitz; John P Klein; John E Wagner; Mei-Jie Zhang; Martin S Tallman; David I Marks; Bruce M Camitta; Richard E Champlin; Olle Ringdén; Christopher N Bredeson; R Martino; Robert Peter Gale; Mitchell S Cairo; Mark R Litzow; M deLima
Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant.
Bone marrow transplantation 2004;34(8):721-7.
2004: Per Ljungman; Johan Aschan; Lisbeth Barkholt; P-A Broliden; B Gustafsson; Ilona Lewensohn-Fuchs; Christina Löfgren; Jacek Winiarski; Olle Ringdén
Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease.
Bone marrow transplantation 2004;34(7):589-93.
2004: Lisbeth Barkholt; Rimma Danielsson; Bertil Calissendorff; Leif Svensson; Reza Malihi; Mats Remberger; Mehmet Uzunel; Anders Thörne; Olle Ringdén
Indium-111-labelled donor-lymphocyte infusion by way of hepatic artery and radio-frequency ablation against liver metastases of renal and colon carcinoma after allogeneic hematopoietic stem-cell transplantation.
Transplantation 2004;78(5):697-703.
2004: Katarina Le Blanc; Ida Rasmusson; Cecilia Götherström; C Seidel; Berit Sundberg; Mikael Sundin; Kerstin Rosendahl; Charlotte Tammik; Olle Ringdén
Mesenchymal stem cells inhibit the expression of CD25 (interleukin-2 receptor) and CD38 on phytohaemagglutinin-activated lymphocytes.
Scandinavian journal of immunology 2004;60(3):307-15.
2004: Gunilla Malm; Jan-Eric Månsson; Jacek Winiarski; Mikael Mosskin; Olle Ringdén
Five-year follow-up of two siblings with aspartylglucosaminuria undergoing allogeneic stem-cell transplantation from unrelated donors.
Transplantation 2004;78(3):415-9.
2004: Mats Remberger; Britt-Marie Svahn; Jonas Mattsson; Olle Ringdén
Dose study of thymoglobulin during conditioning for unrelated donor allogeneic stem-cell transplantation.
Transplantation 2004;78(1):122-7.
2004: Katarina Le Blanc; Ida Rasmusson; Berit Sundberg; Cecilia Götherström; Moustapha Hassan; Mehmet Uzunel; Olle Ringdén
Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells.
Lancet 2004;363(9419):1439-41.
2004: Karl-Henrik Grinnemo; A Månsson; Göran Dellgren; D Klingberg; E Wardell; Viktor Drvota; Charlotte Tammik; J Holgersson; Olle Ringdén; Christer Sylvén; Katarina Le Blanc
Xenoreactivity and engraftment of human mesenchymal stem cells transplanted into infarcted rat myocardium.
The Journal of thoracic and cardiovascular surgery 2004;127(5):1293-300.
2004: Britt-Marie Svahn; B Bjurman; Karl-Erik Myrbäck; Johan Aschan; Olle Ringdén
Is it safe to treat allogeneic stem cell transplanted recipients at home during the pancytopenic phase? A pilot trial.
Presse médicale (Paris, France : 1983) 2004;33(7):474-8.
2004: Anna Nordlander; Jonas Mattsson; Olle Ringdén; Katarina Leblanc; Britt Gustafsson; Per Ljungman; Petter Svenberg; Johan Svennilson; Mats Remberger
Graft-versus-host disease is associated with a lower relapse incidence after hematopoietic stem cell transplantation in patients with acute lymphoblastic leukemia.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(3):195-203.
2004: Kajsa Larsson; Johan Aschan; Mats Remberger; Olle Ringdén; Jacek Winiarski; Per Ljungman
Reduced risk for extensive chronic graft-versus-host disease in patients receiving transplants with human leukocyte antigen-identical sibling donors given polymerase chain reaction-based preemptive therapy against cytomegalovirus.
Transplantation 2004;77(4):526-31.
2004: Olle Ringdén; Marie Schaffer; Katarina Le Blanc; Ulla Persson; Dan Hauzenberger; Mohammad R Abedi; Olle Olerup; Per Ljungman; Mats Remberger
Which donor should be chosen for hematopoietic stem cell transplantation among unrelated HLA-A, -B, and -DRB1 genomically identical volunteers?
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2004;10(2):128-34.
2004: Olle Ringdén; Myriam Labopin; Norbert-Claude Gorin; Katarina Le Blanc; Vanderson Rocha; Eliane Gluckman; Jules Reiffers; William Arcese; Jaak M Vossen; Jean-Pierre Jouet; Catherine Cordonnier; Francesco Frassoni
Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(3):416-23.
2004: Cecilia Götherström; Olle Ringdén; Charlotte Tammik; Eva Zetterberg; Magnus Westgren; Katarina Le Blanc
Immunologic properties of human fetal mesenchymal stem cells.
American journal of obstetrics and gynecology 2004;190(1):239-45.
2004: Nahla Ihendyane; E Sparrelid; B Wretlind; M Remberger; Jan Andersson; P Ljungman; Olle Ringdén; Birgitta Henriques Normark; U Allen; Donald E Low; Anna Norrby-Teglund
Viridans streptococcal septicaemia in neutropenic patients: role of proinflammatory cytokines.
Bone marrow transplantation 2004;33(1):79-85.
2004: Mehmet Uzunel; Olle Ringdén
Poor correlation of kinetics between BCR-ABL and WT1 transcript levels after allogeneic stem cell transplantation.
Bone marrow transplantation 2004;33(1):47-52.
2003: Olle Ringdén
Novel treatment for refractory acute myeloid leukemia.
Pediatric transplantation 2003;7(6):422-5.
2003: Ida Rasmusson; Olle Ringdén; Berit Sundberg; Katarina Le Blanc
Mesenchymal stem cells inhibit the formation of cytotoxic T lymphocytes, but not activated cytotoxic T lymphocytes or natural killer cells.
Transplantation 2003;76(8):1208-13.
2003: Olle Ringdén; Katarina Le Blanc; Outi Hovatta
Transplantation of embryonic stem cells: possibilities and challenges.
Transplantation 2003;76(7):1011-2.
2003: Katarina Le Blanc; Charlotte Tammik; Kerstin Rosendahl; Eva Zetterberg; Olle Ringdén
HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.
Experimental hematology 2003;31(10):890-6.
2003: Katarina Le Blanc; Olle Ringdén; Mats Remberger
A low body mass index is correlated with poor survival after allogeneic stem cell transplantation.
Haematologica 2003;88(9):1044-52.
2003: Marie Schaffer; A Aldener-Cannavá; Mats Remberger; Olle Ringdén; Olle Olerup
Roles of HLA-B, HLA-C and HLA-DPA1 incompatibilities in the outcome of unrelated stem-cell transplantation.
Tissue antigens 2003;62(3):243-50.
2003: Mehmet Uzunel; Marie Jaksch; Jonas Mattsson; Olle Ringdén
Minimal residual disease detection after allogeneic stem cell transplantation is correlated to relapse in patients with acute lymphoblastic leukaemia.
British journal of haematology 2003;122(5):788-94.
2003: F Sjöö; Johan Aschan; Lisbeth Barkholt; Zuzana Hassan; Olle Ringdén; M Hassan
N-acetyl-L-cysteine does not affect the pharmacokinetics or myelosuppressive effect of busulfan during conditioning prior to allogeneic stem cell transplantation.
Bone marrow transplantation 2003;32(4):349-54.
2003: Cecilia Götherström; Olle Ringdén; Magnus Westgren; Charlotte Tammik; Katarina Le Blanc
Immunomodulatory effects of human foetal liver-derived mesenchymal stem cells.
Bone marrow transplantation 2003;32(3):265-72.
2003: Carina Seidel; Olle Ringdén; Mats Remberger
Increased levels of syndecan-1 in serum during acute graft-versus-host disease.
Transplantation 2003;76(2):423-6.
2003: Bim Lindton; Lola Markling; Olle Ringdén; Magnus Westgren
In vitro studies of the role of CD3+ and CD56+ cells in fetal liver cell alloreactivity.
Transplantation 2003;76(1):204-9.
2003: Mats Remberger; N Naseh; Johan Aschan; Lisbeth Barkholt; K LeBlanc; P Svennberg; Olle Ringdén
G-CSF given after haematopoietic stem cell transplantation using HLA-identical sibling donors is associated to a higher incidence of acute GVHD II-IV.
Bone marrow transplantation 2003;32(2):217-23.
2003: Olle Ringdén; A John Barrett; Mei-Jie Zhang; Fausto R Loberiza; Brian J Bolwell; Mitchell S Cairo; Robert Peter Gale; gregory alan hale; Mark R Litzow; Rodrigo Martino; James A Russell; Pierre Tiberghien; Alvaro Urbano-Ispizua; Mary M Horowitz
Decreased treatment failure in recipients of HLA-identical bone marrow or peripheral blood stem cell transplants with high CD34 cell doses.
British journal of haematology 2003;121(6):874-85.
2003: Gunnar Söderdahl; Lisbeth Barkholt; Patrik Hentschke; Jonas Mattsson; Mehmet Uzunel; Bo-Göran Ericzon; Olle Ringdén
Liver transplantation followed by adjuvant nonmyeloablative hemopoietic stem cell transplantation for advanced primary liver cancer in humans.
Transplantation 2003;75(7):1061-6.
2003: Johan Svennilson; Mats Remberger; Olle Ringdén
Risk factors for moderate-to-severe acute graft-vs.-host disease after allogeneic stem cell transplantation in children.
Pediatric transplantation 2003;7(2):130-6.
2003: Christina Nilsson; Johan Aschan; Patrik Hentschke; Olle Ringdén; Per Ljungman; Moustapha Hassan
The effect of metronidazole on busulfan pharmacokinetics in patients undergoing hematopoietic stem cell transplantation.
Bone marrow transplantation 2003;31(6):429-35.
2003: Asa Gustafsson-Jernberg; M Remberger; Olle Ringdén; Jacek Winiarski
Graft-versus-leukaemia effect in children: chronic GVHD has a significant impact on relapse and survival.
Bone marrow transplantation 2003;31(3):175-81.
2003: Patrik Hentschke; Lisbeth Barkholt; Mehmet Uzunel; Jonas Mattsson; Peter Wersäll; Pavel Pisa; J Martola; Nils Albiin; Annika Wernerson; M Söderberg; Mats Remberger; Anders Thörne; Olle Ringdén
Low-intensity conditioning and hematopoietic stem cell transplantation in patients with renal and colon carcinoma.
Bone marrow transplantation 2003;31(4):253-61.
2003: Mehmet Uzunel; Jonas Mattsson; Mats Brune; Jan-Erik Johansson; Johan Aschan; Olle Ringdén
Kinetics of minimal residual disease and chimerism in patients with chronic myeloid leukemia after nonmyeloablative conditioning and allogeneic stem cell transplantation.
Blood 2003;101(2):469-72.
2002: Olle Ringdén; Myriam Labopin; Andrea Bacigalupo; William Arcese; UW Schaefer; Rein Willemze; H Koc; Donald Bunjes; E Gluckman; Vanderson Rocha; Antonius V M B Schattenberg; Francesco Frassoni
Transplantation of peripheral blood stem cells as compared with bone marrow from HLA-identical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(24):4655-64.
2002: Britt-Marie Svahn; Mats Remberger; Karl-Erik Myrbäck; Katarina Holmberg; Britta Eriksson; Patrik Hentschke; Johan Aschan; Lisbeth Barkholt; Olle Ringdén
Home care during the pancytopenic phase after allogeneic hematopoietic stem cell transplantation is advantageous compared with hospital care.
Blood 2002;100(13):4317-24.
2002: Moustapha Hassan; Christina Nilsson; Zuzana Hassan; Tayfun Gungor; Johan Aschan; Jacek Winiarski; Patrik Hentschke; Olle Ringdén; Stefan Eber; Reinhard Seger; Per Ljungman
A phase II trial of liposomal busulphan as an intravenous myeloablative agent prior to stem cell transplantation: 500 mg/m(2) as a optimal total dose for conditioning.
Bone marrow transplantation 2002;30(12):833-41.
2002: Mats Remberger; Jonas Mattsson; Patrik Hentschke; Johan Aschan; Lisbeth Barkholt; Johan Svennilson; Per Ljungman; Olle Ringdén
The graft-versus-leukaemia effect in haematopoietic stem cell transplantation using unrelated donors.
Bone marrow transplantation 2002;30(11):761-8.
2002: Mats Remberger; Ulla Persson; Dan Hauzenberger; Olle Ringdén
An association between human leucocyte antigen alleles and acute and chronic graft-versus-host disease after allogeneic haematopoietic stem cell transplantation.
British journal of haematology 2002;119(3):751-9.
2002: Vanderson Rocha; Myriam Labopin; Eliane Gluckman; Ray Powles; William Arcese; Andrea Bacigalupo; Josy Reiffers; Arturo Iriondo; Olle Ringdén; Tapani Ruutu; Francesco Frassoni
Relevance of bone marrow cell dose on allogeneic transplantation outcomes for patients with acute myeloid leukemia in first complete remission: results of a European survey.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(21):4324-30.
2002: Anna Januszkiewicz; Karin Loré; Pia Essén; B Andersson; Margaret A McNurlan; Peter J Garlick; Olle Ringdén; Jan Andersson; Jan Wernerman
Response of in vivo protein synthesis in T lymphocytes and leucocytes to an endotoxin challenge in healthy volunteers.
Clinical and experimental immunology 2002;130(2):263-70.
2002: Tapani Ruutu; Britta Eriksson; Kari Remes; Eeva Juvonen; Liisa Volin; Mats Remberger; Terttu Parkkali; Hans Hägglund; Olle Ringdén
Ursodeoxycholic acid for the prevention of hepatic complications in allogeneic stem cell transplantation.
Blood 2002;100(6):1977-83.
2002: S Carlens; D Liu; Olle Ringdén; Johan Aschan; Birger Christensson; Victor Levitsky; M Sirac Dilber
Cytolytic T cell reactivity to Epstein-Barr virus is lost during in vitro T cell expansion.
Journal of hematotherapy & stem cell research 2002;11(4):669-74.
2002: Magnus Westgren; Olle Ringdén; Peter Bartmann; The-Hung Bui; Bim Lindton; Jonas Mattsson; Mehmet Uzunel; Henrik Zetterquist; Manfred Hansmann
Prenatal T-cell reconstitution after in utero transplantation with fetal liver cells in a patient with X-linked severe combined immunodeficiency.
American journal of obstetrics and gynecology 2002;187(2):475-82.
2002: Kajsa Larsson; B Lönnqvist; Olle Ringdén; B Hedquist; Per Ljungman
CMV retinitis after allogeneic bone marrow transplantation: a report of five cases.
Transplant infectious disease : an official journal of the Transplantation Society 2002;4(2):75-9.
2002: Patrik Hentschke; Mats Remberger; Jonas Mattsson; Lisbeth Barkholt; Johan Aschan; Per Ljungman; Olle Ringdén
Clinical tolerance after allogeneic hematopoietic stem cell transplantation: a study of influencing factors.
Transplantation 2002;73(6):930-6.
2002: Mats Remberger; Olle Ringdén
Survival after bone-marrow transplantation.
Lancet 2002;359(9309):888.
2002: Mats Remberger; B Storer; Olle Ringdén; C Anasetti
Association between pretransplant Thymoglobulin and reduced non-relapse mortality rate after marrow transplantation from unrelated donors.
Bone marrow transplantation 2002;29(5):391-7.
2002: Jon van Rood; Fausto R Loberiza; Mei-Jie Zhang; Machteld Oudshoorn; Frans H J Claas; Mitchell S Cairo; Richard E Champlin; Robert Peter Gale; Olle Ringdén; Jill M Hows; Mary H Horowitz
Effect of tolerance to noninherited maternal antigens on the occurrence of graft-versus-host disease after bone marrow transplantation from a parent or an HLA-haploidentical sibling.
Blood 2002;99(5):1572-7.
2002: Bim Lindton; Lola Markling; Olle Ringdén; Magnus Westgren
In vitro studies of haematopoietic colony-forming capacity of human fetal liver cells at exposure to cytotoxic and immunomodulatory drugs.
Fetal diagnosis and therapy 2002;17(2):104-9.
2002: Olle Ringdén
Ten years' experience with liposomal amphotericin B in transplant recipients at Huddinge University Hospital.
The Journal of antimicrobial chemotherapy 2002;49 Suppl 1():51-5.
2002: Mats Remberger; Gunilla Kumlien; Johan Aschan; Lisbeth Barkholt; Patrik Hentschke; Per Ljungman; Jonas Mattsson; Johan Svennilson; Olle Ringdén
Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2002;8(12):674-82.
2002: Per Ljungman; Kajsa Larsson; Gunilla Kumlien; Johan Aschan; Lisbeth Barkholt; Asa Gustafsson-Jernberg; Ilona Lewensohn-Fuchs; Olle Ringdén
Leukocyte depleted, unscreened blood products give a low risk for CMV infection and disease in CMV seronegative allogeneic stem cell transplant recipients with seronegative stem cell donors.
Scandinavian journal of infectious diseases 2002;34(5):347-50.
2001: Jonas Mattsson; Mehmet Uzunel; M Brune; Patrik Hentschke; Lisbeth Barkholt; Ulrika Stierner; Johan Aschan; Olle Ringdén
Mixed chimaerism is common at the time of acute graft-versus-host disease and disease response in patients receiving non-myeloablative conditioning and allogeneic stem cell transplantation.
British journal of haematology 2001;115(4):935-44.
2001: Henrik Zetterquist; Patrik Hentschke; Anders Thörne; Annika Wernerson; Jonas Mattsson; Mehmet Uzunel; J Martola; Nils Albiin; Johan Aschan; Nikos Papadogiannakis; Olle Ringdén
A graft-versus-colonic cancer effect of allogeneic stem cell transplantation.
Bone marrow transplantation 2001;28(12):1161-6.
2001: Jonas Mattsson; Mehmet Uzunel; L Tammik; Johan Aschan; Olle Ringdén
Leukemia lineage-specific chimerism analysis is a sensitive predictor of relapse in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic stem cell transplantation.
Leukemia 2001;15(12):1976-85.
2001: Anna Januszkiewicz; Pia Essén; Margaret A McNurlan; Olle Ringdén; Peter J Garlick; Jan Wernerman
A combined stress hormone infusion decreases in vivo protein synthesis in human T lymphocytes in healthy volunteers.
Metabolism: clinical and experimental 2001;50(11):1308-14.
2001: Mehmet Uzunel; Jonas Mattsson; Marie Jaksch; Mats Remberger; Olle Ringdén
The significance of graft-versus-host disease and pretransplantation minimal residual disease status to outcome after allogeneic stem cell transplantation in patients with acute lymphoblastic leukemia.
Blood 2001;98(6):1982-4.
2001: Mats Remberger; Olle Ringdén; Igor Wolfgang Blau; Hellmut D Ottinger; Bernhard Kremens; Michael Kiehl; Johan Aschan; Dietrich W Beelen; Nadezda Basara; Gunilla Kumlien; Axel A Fauser; Volker Runde
No difference in graft-versus-host disease, relapse, and survival comparing peripheral stem cells to bone marrow using unrelated donors.
Blood 2001;98(6):1739-45.
2001: Mats Remberger; Johan Aschan; Lisbeth Barkholt; J Tollemar; Olle Ringdén
Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin.
Clinical transplantation 2001;15(3):147-53.
2001: Anna Januszkiewicz; Pia Essén; Margaret A McNurlan; Olle Ringdén; Peter J Garlick; Jan Wernerman
Determination of in vivo protein synthesis in human T lymphocytes.
Clinical nutrition (Edinburgh, Scotland) 2001;20(2):181-2.
2001: Alexandra H Filipovich; JV Stone; Sandra C Tomany; M Ireland; Craig Kollman; CJ Pelz; James T Casper; M J Cowan; J R Edwards; A Fasth; Robert Peter Gale; A Junker; Naynesh Kamani; Brett Loechelt; Daniel Pietryga; Olle Ringdén; MR Vowels; Janet Hegland; A V Williams; John P Klein; Kathleen A Sobocinski; Philip Rowlings; Mary M Horowitz
Impact of donor type on outcome of bone marrow transplantation for Wiskott-Aldrich syndrome: collaborative study of the International Bone Marrow Transplant Registry and the National Marrow Donor Program.
Blood 2001;97(6):1598-603.
2001: Zuzana Hassan; P Ljungman; Olle Ringdén; Jacek Winiarski; C Nilsson; Johan Aschan; H R Whitley; Moustapha Hassan
Pharmacokinetics of liposomal busulphan in man.
Bone marrow transplantation 2001;27(5):479-85.
2001: Jonas Mattsson; Mehmet Uzunel; Mats Remberger; Olle Ringdén
T cell mixed chimerism is significantly correlated to a decreased risk of acute graft-versus-host disease after allogeneic stem cell transplantation.
Transplantation 2001;71(3):433-9.
2001: Lisbeth Barkholt; Patrik Hentschke; Henrik Zetterquist; Jonas Mattsson; Mehmet Uzunel; Peter Wersäll; J Martola; N Albin; Johan Aschan; Hans Wijkström; A Tillegård; S Oman; Annika Wernerson; Dietger Niederwieser; Anders Thörne; Olle Ringdén
An allogeneic anti-cancer effect after hematopoietic stem cell transplantation.
Transplantation proceedings 2001;33(1-2):1862-4.
2001: Mats Remberger; Johan Aschan; B Lönnqvist; S Carlens; B Gustafsson; Patrik Hentschke; S Klaesson; Jonas Mattsson; Per Ljungman; Olle Ringdén
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation.
Transplantation proceedings 2001;33(1-2):1769-70.
2001: S Carlens; Mats Remberger; Johan Aschan; Olle Ringdén
The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(1):31-8.
2001: Mats Remberger; Johan Aschan; B Lönnqvist; S Carlens; B Gustafsson; Patrik Hentschke; S Klaesson; Jonas Mattsson; Per Ljungman; Olle Ringdén
An ethnic role for chronic, but not acute, graft-versus-host disease after HLA-identical sibling stem cell transplantation.
European journal of haematology 2001;66(1):50-6.
2001: Jonas Mattsson; Mehmet Uzunel; Mats Remberger; L Tammik; Brigitta Omazic; Victor Levitsky; Jie-Zhi Zou; Patrik Hentschke; Olle Ringdén
Poor immune reconstitution after four or five major HLA antigens mismatched T cell-depleted allogeneic and autologous stem cell transplantation.
Clinical and experimental immunology 2001;123(1):162-9.
2001: Bim Lindton; Thomas Tolfvenstam; Oscar Norbeck; Lola Markling; Olle Ringdén; Magnus Westgren; Kristina Broliden
Recombinant parvovirus B19 empty capsids inhibit fetal hematopoietic colony formation in vitro.
Fetal diagnosis and therapy 2001;16(1):26-31.
2000: Olle Ringdén; Myriam Labopin; Norbert-Claude Gorin; Norbert Schmitz; UW Schaefer; H G Prentice; L Bergmann; Jean-Pierre Jouet; F Mandelli; D Blaise; Loïc Fouillard; Francesco Frassoni
Is there a graft-versus-leukaemia effect in the absence of graft-versus-host disease in patients undergoing bone marrow transplantation for acute leukaemia?
British journal of haematology 2000;111(4):1130-7.
2000: Per Ljungman; F Z Wang; D A Clark; V C Emery; M Remberger; Olle Ringdén; A Linde
High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients.
British journal of haematology 2000;111(3):774-81.
2000: Britt-Marie Svahn; B Bjurman; Karl-Erik Myrbäck; Johan Aschan; Olle Ringdén
Is it safe to treat allogeneic stem cell transplant recipients at home during the pancytopenic phase? A pilot trial.
Bone marrow transplantation 2000;26(10):1057-60.
2000: Elisabet Akesson; Lola Markling; Anders Kjaeldgaard; Scott Paul Falci; Olle Ringdén
MHC antigen expression in human first trimester spinal cord with implications for clinical transplantation procedures.
Journal of neuroimmunology 2000;111(1-2):210-4.
2000: Mats Bågesund; Sven Richter; B Agren; Olle Ringdén; Göran Dahllöf
Scintigraphic study of the major salivary glands in pediatric bone marrow transplant recipients.
Bone marrow transplantation 2000;26(7):775-9.
2000: Moustapha Hassan; Jan-Olof Svensson; Christina Nilsson; Patrik Hentschke; Ayman Al-Shurbaji; Johan Aschan; Per Ljungman; Olle Ringdén
Ketobemidone may alter busulfan pharmacokinetics during high-dose therapy.
Therapeutic drug monitoring 2000;22(4):383-5.
2000: Richard E Champlin; Jakob R Passweg; Mei-Jie Zhang; Philip Rowlings; CJ Pelz; KA Atkinson; A John Barrett; Jean-Yves Cahn; William R Drobyski; Robert Peter Gale; John M Goldman; Alois Gratwohl; Edward C Gordon-Smith; PJ Henslee-Downey; Roger H Herzig; John P Klein; Alberto M Marmont; Richard J O'Reilly; Olle Ringdén; S Slavin; Kathleen A Sobocinski; B Speck; R S Weiner; Mary M Horowitz
T-cell depletion of bone marrow transplants for leukemia from donors other than HLA-identical siblings: advantage of T-cell antibodies with narrow specificities.
Blood 2000;95(12):3996-4003.
2000: Richard E Champlin; Norbert Schmitz; Mary M Horowitz; B Chapuis; R Chopra; J J Cornelissen; Robert Peter Gale; John M Goldman; Fausto R Loberiza; B Hertenstein; John P Klein; E Montserrat; Mei-Jie Zhang; Olle Ringdén; Sandra C Tomany; Philip Rowlings; M E Van Hoef; Alois Gratwohl
Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT).
Blood 2000;95(12):3702-9.
2000: A John Barrett; Olle Ringdén; Mei-Jie Zhang; Asad Bashey; Jean-Yves Cahn; Mitchell S Cairo; Robert Peter Gale; Alois Gratwohl; F Locatelli; Rodrigo Martino; Kirk R Schultz; Pierre Tiberghien
Effect of nucleated marrow cell dose on relapse and survival in identical twin bone marrow transplants for leukemia.
Blood 2000;95(11):3323-7.
2000: Olle Ringdén; Gunnar Söderdahl; Jonas Mattsson; Mehmet Uzunel; Mats Remberger; Patrik Hentschke; Hans Hägglund; Elda Sparrelid; A Elmhorn-Rosenborg; Frans Duraj; Henrik Zetterquist; Bo-Göran Ericzon
Transplantation of autologous and allogeneic bone marrow with liver from a cadaveric donor for primary liver cancer.
Transplantation 2000;69(10):2043-8.
2000: Olle Ringdén; Mats Remberger; Volker Runde; Martin Bornhäuser; Igor Wolfgang Blau; Nadezda Basara; Kristina Hölig; Dietrich W Beelen; Hans Hägglund; Oliver Basu; Gerhard Ehninger; Axel A Fauser
Faster engraftment of neutrophils and platelets with peripheral blood stem cells from unrelated donors: a comparison with marrow transplantation.
Bone marrow transplantation 2000;25 Suppl 2():S6-8.
2000: Olle Ringdén; Myriam Labopin; Norbert-Claude Gorin; G Meloni; D Blaise; J Reiffers; Kristina Carlson; Loïc Fouillard; Francesco Frassoni
The dismal outcome in patients with acute leukaemia who relapse after an autograft is improved if a second autograft or a matched allograft is performed. Acute Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Bone marrow transplantation 2000;25(10):1053-8.
2000: Olle Ringdén; Mats Remberger; S Lehmann; Patrik Hentschke; Jonas Mattsson; S Klaesson; Johan Aschan
N-acetylcysteine for hepatic veno-occlusive disease after allogeneic stem cell transplantation.
Bone marrow transplantation 2000;25(9):993-6.
2000: Henrik Zetterquist; Jonas Mattsson; Mehmet Uzunel; Ingrid Näsman-Björk; Petter Svenberg; L Tammik; G Bayat; Jacek Winiarski; Olle Ringdén
Mixed chimerism in the B cell lineage is a rapid and sensitive indicator of minimal residual disease in bone marrow transplant recipients with pre-B cell acute lymphoblastic leukemia.
Bone marrow transplantation 2000;25(8):843-51.
2000: Bim Lindton; Lola Markling; Olle Ringdén; Anders Kjaeldgaard; O Gustafson; Magnus Westgren
Mixed lymphocyte culture of human fetal liver cells.
Fetal diagnosis and therapy 2000;15(2):71-8.
2000: Anna Januszkiewicz; Pia Essén; Margaret A McNurlan; Olle Ringdén; Jan Wernerman; Peter J Garlick
In vivo protein synthesis of circulating human T lymphocytes does not respond to a cortisol challenge within 24 h.
Acta anaesthesiologica Scandinavica 2000;44(2):202-9.
2000: Jonas Mattsson; Mehmet Uzunel; Mats Remberger; P Ljungman; E Kimby; Olle Ringdén; Henrik Zetterquist
Minimal residual disease is common after allogeneic stem cell transplantation in patients with B cell chronic lymphocytic leukemia and may be controlled by graft-versus-host disease.
Leukemia 2000;14(2):247-54.
2000: I N Björk; C Brissac; Mats Remberger; Jonas Mattsson; S Klaesson; Olle Ringdén; J Stewart; Inger Lundkvist
Long-term persistence of oligoclonal serum IgM repertoires in patients treated with allogeneic bone marrow transplantation (BMT).
Clinical and experimental immunology 2000;119(1):240-9.
1999: Patrik Hentschke; Hans Hägglund; Jonas Mattsson; S Carlens; B Lönnqvist; Per Ljungman; Johan Aschan; Sten Fredrikson; Olle Ringdén
Bilateral subdural haematomas following lumbar puncture in three haematopoietic stem cell transplant recipients.
Bone marrow transplantation 1999;24(9):1033-5.
1999: Hans Hägglund; Olle Ringdén; S Oman; Mats Remberger; S Carlens; Jonas Mattsson
A prospective randomized trial of Filgrastim (r-metHuG-CSF) given at different times after unrelated bone marrow transplantation.
Bone marrow transplantation 1999;24(8):831-6.
1999: Mats Remberger; Britt-Marie Svahn; Patrik Hentschke; Christina Löfgren; Olle Ringdén
Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation.
Bone marrow transplantation 1999;24(8):823-30.
1999: S Carlens; Johan Aschan; Mats Remberger; M Sirac Dilber; Olle Ringdén
Low-dose cyclosporine of short duration increases the risk of mild and moderate GVHD and reduces the risk of relapse in HLA-identical sibling marrow transplant recipients with leukaemia.
Bone marrow transplantation 1999;24(6):629-35.
1999: Olle Ringdén; Mats Remberger; Volker Runde; Martin Bornhäuser; Igor Wolfgang Blau; Nadezda Basara; Kristina Hölig; Dietrich W Beelen; Hans Hägglund; Oliver Basu; Gerhard Ehninger; Axel A Fauser
Peripheral blood stem cell transplantation from unrelated donors: a comparison with marrow transplantation.
Blood 1999;94(2):455-64.
1999: Olle Ringdén; Mats Remberger; Tapani Ruutu; J Nikoskelainen; Liisa Volin; Lars L Vindeløv; Terttu Parkkali; Stig Lenhoff; B Sallerfors; L Mellander; Per Ljungman; Niels Jacobsen
Increased risk of chronic graft-versus-host disease, obstructive bronchiolitis, and alopecia with busulfan versus total body irradiation: long-term results of a randomized trial in allogeneic marrow recipients with leukemia. Nordic Bone Marrow Transplantation Group.
Blood 1999;93(7):2196-201.
1999: J Tollemar; N Gross; N Dolgiras; Connie Jarstrand; Olle Ringdén; Lennart Hammarström
Fungal prophylaxis by reduction of fungal colonization by oral administration of bovine anti-Candida antibodies in bone marrow transplant recipients.
Bone marrow transplantation 1999;23(3):283-90.
1998: Hans Hägglund; Mats Remberger; S Klaesson; B Lönnqvist; Per Ljungman; Olle Ringdén
Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation.
Blood 1998;92(12):4568-72.
1998: Per Ljungman; Johan Aschan; Ilona Lewensohn-Fuchs; S Carlens; Kajsa Larsson; B Lönnqvist; Jonas Mattsson; Elda Sparrelid; Jacek Winiarski; Olle Ringdén
Results of different strategies for reducing cytomegalovirus-associated mortality in allogeneic stem cell transplant recipients.
Transplantation 1998;66(10):1330-4.
1998: Elda Sparrelid; Hans Hägglund; Mats Remberger; Olle Ringdén; B Lönnqvist; Per Ljungman; Jan Andersson
Bacteraemia during the aplastic phase after allogeneic bone marrow transplantation is associated with early death from invasive fungal infection.
Bone marrow transplantation 1998;22(8):795-800.
1998: S Carlens; Olle Ringdén; Mats Remberger; B Lönnqvist; Hans Hägglund; S Klaesson; Jonas Mattsson; Britt-Marie Svahn; Jacek Winiarski; Per Ljungman; Johan Aschan
Risk factors for chronic graft-versus-host disease after bone marrow transplantation: a retrospective single centre analysis.
Bone marrow transplantation 1998;22(8):755-61.
1998: Olle Ringdén; Mats Remberger; S Carlens; H Hagglund; Jonas Mattsson; Johan Aschan; B Lönnqvist; S Klaesson; Jacek Winiarski; Tina Dalianis; Olle Olerup; Elda Sparrelid; A Elmhorn-Rosenborg; Britt-Marie Svahn; Per Ljungman
Low incidence of acute graft-versus-host disease, using unrelated HLA-A-, HLA-B-, and HLA-DR-compatible donors and conditioning, including anti-T-cell antibodies.
Transplantation 1998;66(5):620-5.
1998: Per Ljungman; R Halasz; Hans Hägglund; Anders Sönnerborg; Olle Ringdén
Detection of hepatitis G virus/GB virus C after allogeneic bone marrow transplantation.
Bone marrow transplantation 1998;22(5):499-501.
1998: Olle Ringdén; Volker Runde; Hans Hägglund; Oliver Basu; M Potter
Transplantation of peripheral blood progenitor cells from unrelated donors.
Transplantation 1998;66(1):142-3.
1998: Hans Hägglund; Olle Ringdén; Mats Remberger; B Lönnqvist; Elda Sparrelid; L Tammik; G Kumlien
Faster neutrophil and platelet engraftment, but no differences in acute GVHD or survival, using peripheral blood stem cells from related and unrelated donors, compared to bone marrow.
Bone marrow transplantation 1998;22(2):131-6.
1998: Mats Remberger; Olle Ringdén; Per Ljungman; Hans Hägglund; Jacek Winiarski; B Lönnqvist; Johan Aschan
Booster marrow or blood cells for graft failure after allogeneic bone marrow transplantation.
Bone marrow transplantation 1998;22(1):73-8.
1998: Olle Ringdén; Hans Hägglund; Volker Runde; Oliver Basu; F Kroschinsky; M Stockschläder; M N Potter
Faster engraftment of peripheral blood progenitor cells compared to bone marrow from unrelated donors.
Bone marrow transplantation 1998;21 Suppl 3():S81-4.
1998: Jacek Winiarski; Jonas Mattsson; A Gustafsson; Daniela Wester; B Borgström; Olle Ringdén; P Ljungman; Tina Dalianis
Engraftment and chimerism, particularly of T- and B-cells, in children undergoing allogeneic bone marrow transplantation.
Pediatric transplantation 1998;2(2):150-6.
1998: S Carlens; Olle Ringdén; Johan Aschan; Hans Hägglund; Per Ljungman; Jonas Mattsson; Mats Remberger
Risk factors in bone marrow transplant recipients with leukaemia. Increased relapse risk in patients treated with ciprofloxacin for gut decontamination.
Clinical transplantation 1998;12(2):84-92.
1998: Hans Hägglund; Olle Ringdén; B Agren; Lars Wennberg; Mats Remberger; L Rundquist; Britt-Marie Svahn; P Aspelin
Intraosseous compared to intravenous infusion of allogeneic bone marrow.
Bone marrow transplantation 1998;21(4):331-5.
1998: Gunnar Söderdahl; C Tammik; Mats Remberger; Olle Ringdén
Cadaveric bone marrow and spleen cells for transplantation.
Bone marrow transplantation 1998;21(1):79-84.
1998: Olle Ringdén; Mats Remberger; Jonas Mattsson; Johan Aschan; S Carlens; Hans Hägglund; B Lönnqvist; Elda Sparrelid; Per Ljungman
Transplantation with unrelated bone marrow in leukaemic patients above 40 years of age.
Bone marrow transplantation 1998;21(1):43-9.
1997: Per Ljungman; M Hassan; A N Békássy; Olle Ringdén; Gunnar Oberg
High busulfan concentrations are associated with increased transplant-related mortality in allogeneic bone marrow transplant patients.
Bone marrow transplantation 1997;20(11):909-13.
1997: Olle Ringdén; E E Andström; Mats Remberger; Göran Dahllöf; Britt-Marie Svahn; J Tollemar
Prophylaxis and therapy using liposomal amphotericin B (AmBisome) for invasive fungal infections in children undergoing organ or allogeneic bone-marrow transplantation.
Pediatric transplantation 1997;1(2):124-9.
1997: Per Ljungman; Hans Hägglund; Bo Björkstrand; B Lönnqvist; Olle Ringdén
Peroperative teicoplanin for prevention of gram-positive infections in neutropenic patients with indwelling central venous catheters: a randomized, controlled study.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 1997;5(6):485-8.
1997: S Carlens; Olle Ringdén; Mats Remberger; Jonas Mattsson; Johan Aschan; Hans Hägglund; Per Ljungman
Factors affecting risk of relapse and leukemia-free survival in HLA-identical sibling marrow transplant recipients with leukemia.
Transplantation proceedings 1997;29(7):3147-9.
1997: Olle Ringdén; Mats Remberger; Jonas Mattsson; Johan Aschan; Hans Hägglund; S Carlens; B Lönnqvist; Elda Sparrelid; Per Ljungman
Transplantation with unrelated bone marrow in leukemic patients above 40 years of age.
Transplantation proceedings 1997;29(7):3145-6.
1997: Hans Hägglund; Jacek Winiarski; Olle Ringdén; Elda Sparrelid; Bo-Göran Ericzon
Successful allogeneic bone marrow transplantation in a 2.5-year-old boy with ongoing cytomegalovirus viremia and severe aplastic anemia after orthotopic liver transplantation for non-A, non-B, non-C hepatitis.
Transplantation 1997;64(8):1207-8.
1997: Göran Dahllöf; Mats Bågesund; Mats Remberger; Olle Ringdén
Risk factors for salivary dysfunction in children 1 year after bone marrow transplantation.
Oral oncology 1997;33(5):327-31.
1997: Göran Dahllöf; Mats Bågesund; Olle Ringdén
Impact of conditioning regimens on salivary function, caries-associated microorganisms and dental caries in children after bone marrow transplantation. A 4-year longitudinal study.
Bone marrow transplantation 1997;20(6):479-83.
1997: A Shanwell; Marianne Kristiansson; M Remberger; Olle Ringdén
Generation of cytokines in red cell concentrates during storage is prevented by prestorage white cell reduction.
Transfusion 1997;37(7):678-84.
1997: Elda Sparrelid; Per Ljungman; E Ekelöf-Andström; Johan Aschan; Olle Ringdén; Jacek Winiarski; B Wåhlin; Jan Andersson
Ribavirin therapy in bone marrow transplant recipients with viral respiratory tract infections.
Bone marrow transplantation 1997;19(9):905-8.
1997: Jonas Mattsson; Olle Ringdén; Johan Aschan; Lisbeth Barkholt; Tina Dalianis; Hans Hägglund; Per Ljungman; B Lönnqvist; J Tollemar; Jacek Winiarski; Mats Remberger
A low incidence of grade II to IV acute GVHD, but high mortality from infection using HLA-A, -B, and -DR-identical unrelated donors and immunosuppression with ATG, cyclosporine, and methotrexate.
Transplantation proceedings 1997;29(1-2):735-6.
1997: Olle Ringdén; Myriam Labopin; E Gluckman; J Reiffers; J P Vernant; J P Jouet; Jean-Luc Harousseau; Denis Fiere; A Bacigalupo; F Frassoni; N C Gorin
Strong antileukemic effect of chronic graft-versus-host disease in allogeneic marrow transplant recipients having acute leukemia treated with methotrexate and cyclosporine. The Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).
Transplantation proceedings 1997;29(1-2):733-4.
1997: Gunnar Söderdahl; C Tammik; Mats Remberger; J Sandberg; G Tufveson; J Tollemar; Olle Ringdén
Immune markers and hematopoiesis of cadaveric bone marrow for transplantation.
Transplantation proceedings 1997;29(1-2):714-5.
1997: Tapani Ruutu; Per Ljungman; Lorentz Brinch; Stig Lenhoff; B Lönnqvist; Olle Ringdén; Petri Ruutu; Liisa Volin; D Albrechtsen; B Sallerfors; Freja Ebeling; G Myllylä
No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group.
Bone marrow transplantation 1997;19(3):233-6.
1996: Per Ljungman; M Lawler; B Lönnqvist; Olle Ringdén; A Shanwell
Rejection of the second allogeneic graft in a patient with severe aplastic anemia reversed by antilymphocyte globulin and donor lymphocyte infusions.
Bone marrow transplantation 1996;18(6):1179-81.
1996: Olle Ringdén; M Labopin; E Gluckman; J Reiffers; J P Vernant; J P Jouet; J L Harrousseau; D Fiere; A Bacigalupo; F Frassoni; N C Gorin
Graft-versus-leukemia effect in allogeneic marrow transplant recipients with acute leukemia is maintained using cyclosporin A combined with methotrexate as prophylaxis. Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
Bone marrow transplantation 1996;18(5):921-9.
1996: D R Jones; T H Bui; E M Anderson; Sverker Ek; D Liu; Olle Ringdén; Magnus Westgren
In utero haematopoietic stem cell transplantation: current perspectives and future potential.
Bone marrow transplantation 1996;18(5):831-7.
1996: H Hágglund; Olle Ringdén; Bo-Göran Ericzon; Frans Duraj; Per Ljungman; B Lönnqvist; Jacek Winiarski; Gunnar Tydén
Treatment of hepatic venoocclusive disease with recombinant human tissue plasminogen activator or orthotopic liver transplantation after allogeneic bone marrow transplantation.
Transplantation 1996;62(8):1076-80.
1996: Sverker Ek; L Markling; Olle Ringdén; A Kjeldgaard; Magnus Westgren
Colony formation of human fetal CD34+ hematopoietic cells.
Fetal diagnosis and therapy 1996;11(5):326-34.
1996: Sverker Ek; Magnus Westgren; L Markling; A Kjeldgaard; Olle Ringdén
Cytokine stimulation of human fetal hematopoietic cells.
Fetal diagnosis and therapy 1996;11(5):318-25.
1996: Per Ljungman; J Andersson; Johan Aschan; Bo Björkstrand; Hans Hägglund; B Lönnqvist; Olle Ringdén; Jacek Winiarski
Oral ribavirin for prevention of severe liver disease caused by hepatitis C virus during allogeneic bone marrow transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(1):167-9.
1996: Gunilla Malm; Olle Ringdén; J Winiarski; E Gröndahl; P Uyebrant; U Eriksson; H Håkansson; O Skjeldal; J E Månsson
Clinical outcome in four children with metachromatic leukodystrophy treated by bone marrow transplantation.
Bone marrow transplantation 1996;17(6):1003-8.
1996: E E Andström; Olle Ringdén; Mats Remberger; Britt-Marie Svahn; J Tollemar
Safety and efficacy of liposomal amphotericin B in allogeneic bone marrow transplant recipients.
Mycoses 1996;39(5-6):185-93.
1996: S Klaesson; L Tammik; L Markling; Inger Lundkvist; Olle Ringdén
Inhibition of immunoglobulin production in vitro by IgG and F(ab')2 fragments, but not by the Fc portion.
Scandinavian journal of immunology 1996;43(5):574-82.
1996: Per Ljungman; K Loré; Johan Aschan; S Klaesson; Ilona Lewensohn-Fuchs; B Lönnqvist; Olle Ringdén; Jacek Winiarski; A Ehrnst
Use of a semi-quantitative PCR for cytomegalovirus DNA as a basis for pre-emptive antiviral therapy in allogeneic bone marrow transplant patients.
Bone marrow transplantation 1996;17(4):583-7.
1996: Jacek Winiarski; Olle Ringdén; Mats Remberger; Tina Dalianis; Per Ljungman; B Borgström
Bone marrow transplantation in children using unrelated donors at Huddinge Hospital.
Acta paediatrica (Oslo, Norway : 1992) 1996;85(3):327-35.
1995: S Klaesson; Olle Ringdén; Per Ljungman; Johan Aschan; Hans Hägglund; Jacek Winiarski
Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?
Transplantation 1995;60(11):1225-30.
1995: S Klaesson; Olle Ringdén; L Markling; L Tammik
Intravenous immunoglobulin: immune modulatory effects in vitro and clinical effects in allogeneic bone marrow transplant recipients.
Transplantation proceedings 1995;27(6):3536-7.
1995: Elda Sparrelid; Hans Hägglund; Mats Remberger; Per Ljungman; A S Malmborg; Jacek Winiarski; J Andersson; Olle Ringdén
Risk factors for septicemia during aplastic period after allogeneic bone marrow transplantation.
Transplantation proceedings 1995;27(6):3530.
1995: Maria Brytting; Mehrdad Mousavi-Jazi; L Boström; M Larsson; J Lunderberg; Per Ljungman; Olle Ringdén; V A Sundqvist
Cytomegalovirus DNA in peripheral blood leukocytes and plasma from bone marrow transplant recipients.
Transplantation 1995;60(9):961-5.
1995: J Tollemar; Olle Ringdén
Lipid formulations of amphotericin B. Less toxicity but at what economic cost?
Drug safety : an international journal of medical toxicology and drug experience 1995;13(4):207-18.
1995: Per Ljungman; N Johansson; Johan Aschan; H Glaumann; B Lönnqvist; Olle Ringdén; Elda Sparrelid; Anders Sönnerborg; Jacek Winiarski; Gösta Gahrton
Long-term effects of hepatitis C virus infection in allogeneic bone marrow transplant recipients.
Blood 1995;86(4):1614-8.
1995: Per Ljungman; M Hassan; A N Békássy; Olle Ringdén; Gunnar Oberg
Busulfan concentration in relation to permanent alopecia in recipients of bone marrow transplants.
Bone marrow transplantation 1995;15(6):869-71.
1995: Olle Ringdén; Mats Remberger; U Persson; Per Ljungman; A Aldener; E Andström; Johan Aschan; P Bolme; G Dahllöf; Tina Dalianis
Similar incidence of graft-versus-host disease using HLA-A, -B and -DR identical unrelated bone marrow donors as with HLA-identical siblings.
Bone marrow transplantation 1995;15(4):619-25.
1995: Olle Ringdén; Carl G Groth; A Erikson; S Granqvist; J E Månsson; Elda Sparrelid
Ten years' experience of bone marrow transplantation for Gaucher disease.
Transplantation 1995;59(6):864-70.
1995: P Bolme; Jan-Inge Henter; Jacek Winiarski; Göran Elinder; Per Ljungman; G Lönnerholm; Olle Ringdén
Allogeneic bone marrow transplantation for hemophagocytic lymphohistiocytosis in Sweden.
Bone marrow transplantation 1995;15(3):331-5.
1995: J Tollemar; K Höckerstedt; Bo-Göran Ericzon; H Jalanko; Olle Ringdén
Prophylaxis with liposomal amphotericin B (AmBisome) prevents fungal infections in liver transplant recipients: long-term results of a randomized, placebo-controlled trial.
Transplantation proceedings 1995;27(1):1195-8.
1995: J Tollemar; K Höckerstedt; Bo-Göran Ericzon; H Jalanko; Olle Ringdén
Liposomal amphotericin B prevents invasive fungal infections in liver transplant recipients. A randomized, placebo-controlled study.
Transplantation 1995;59(1):45-50.
1994: Sverker Ek; Magnus Westgren; H Pschera; Ake Seiger; E Sundström; T H Bui; Olle Ringdén
Screening of fetal stem cells for infection and cytogenetic abnormalities.
Fetal diagnosis and therapy 1994;9(6):357-61.
1994: Olle Ringdén; Mats Remberger; Johan Aschan; P Lungman; B Lönnqvist; L Markling
Long-term follow-up of a randomized trial comparing T cell depletion with a combination of methotrexate and cyclosporine in adult leukemic marrow transplant recipients.
Transplantation 1994;58(8):887-91.
1994: Olle Ringdén; E Andström; M Remberger; Britt-Marie Svahn; J Tollemar
Allergic reactions and other rare side-effects of liposomal amphotericin.
Lancet 1994;344(8930):1156-7.
1994: Per Ljungman; M Lawler; B Asjö; G Bogdanovic; K Karlsson; C Malm; S R McCann; Olle Ringdén; Gösta Gahrton
Infection of donor lymphocytes with human T lymphotrophic virus type 1 (HTLV-I) following allogeneic bone marrow transplantation for HTLV-I positive adult T-cell leukaemia.
British journal of haematology 1994;88(2):403-5.
1994: Per Ljungman; Ilona Lewensohn-Fuchs; V Hammarström; Johan Aschan; L Brandt; P Bolme; B Lönnqvist; N Johansson; Olle Ringdén; Gösta Gahrton
Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation.
Blood 1994;84(2):657-63.
1994: Sverker Ek; Olle Ringdén; L Markling; Magnus Westgren
Immunological capacity of human fetal liver cells.
Bone marrow transplantation 1994;14(1):9-14.
1994: Johan Aschan; Olle Ringdén; E Andström; Per Ljungman; B Lönnqvist; Mats Remberger
Individualized prophylaxis against graft-versus-host disease in leukemic marrow transplant recipients.
Bone marrow transplantation 1994;14(1):79-87.
1994: Olle Ringdén; Mats Remberger; U Persson; Per Ljungman; Johan Aschan; P Bolme; G Dahllöf; Tina Dalianis; G Gahrton; B Lönnqvist
[New facts about bone marrow transplantation. An unrelated donor is as good as a related one].
Läkartidningen 1994;91(26-27):2577-82.
1994: Johan Aschan; Olle Ringdén
Prognostic factors for long-term survival in leukemic marrow recipients with special emphasis on age and prophylaxis for graft-versus-host disease.
Clinical transplantation 1994;8(3 Pt 1):258-70.
1994: J Tollemar; K Höckerstedt; B G Ericzon; B Sundberg; Olle Ringdén
Fungal prophylaxis with AmBisome in liver and bone marrow transplant recipients: results of two randomized double-blind studies.
Transplantation proceedings 1994;26(3):1833.
1994: Olle Ringdén; Tapani Ruutu; Mats Remberger; J Nikoskelainen; Liisa Volin; L Vindeløv; Terttu Parkkali; Stig Lenhoff; B Sallerfors; Per Ljungman
A randomized trial comparing busulfan vs total body irradiation in allogeneic marrow transplant recipients with hematological malignancies.
Transplantation proceedings 1994;26(3):1831-2.
1994: S Klaesson; Olle Ringdén; Per Ljungman; B Lönnqvist; Lars Wennberg
Treatment with erythropoietin after allogeneic bone marrow transplantation: a randomized, double-blind study.
Transplantation proceedings 1994;26(3):1827-8.
1994: Johan Aschan; Olle Ringdén; E Andström; Per Ljungman; Mats Remberger
Prevention of graft-versus-host disease on an individual basis.
Transplantation proceedings 1994;26(3):1823-4.
1994: Olle Ringdén; Tapani Ruutu; Mats Remberger; J Nikoskelainen; Liisa Volin; L Vindeløv; Terttu Parkkali; Stig Lenhoff; B Sallerfors; Per Ljungman
A randomized trial comparing busulfan with total body irradiation as conditioning in allogeneic marrow transplant recipients with leukemia: a report from the Nordic Bone Marrow Transplantation Group.
Blood 1994;83(9):2723-30.
1994: Göran Dahllöf; Larisa Krekmanova; S Kopp; B Borgström; Carl-Magnus Forsberg; Olle Ringdén
Craniomandibular dysfunction in children treated with total-body irradiation and bone marrow transplantation.
Acta odontologica Scandinavica 1994;52(2):99-105.
1994: S Klaesson; Olle Ringdén; Per Ljungman; B Lönnqvist; Lars Wennberg
Reduced blood transfusions requirements after allogeneic bone marrow transplantation: results of a randomised, double-blind study with high-dose erythropoietin.
Bone marrow transplantation 1994;13(4):397-402.
1994: Olle Ringdén; J Tollemar; G Dahllöf; G Tydén
High cure rate of invasive fungal infections in immunocompromised children using ambisome.
Transplantation proceedings 1994;26(1):175-7.
1994: Olle Ringdén; E Andström; Mats Remberger; Britt-Marie Svahn; J Tollemar
Safety of liposomal amphotericin B (AmBisome) in 187 transplant recipients treated with cyclosporin.
Bone marrow transplantation 1994;14 Suppl 5():S10-4.
1993: J Tollemar; Olle Ringdén; S Andersson; B Sundberg; Per Ljungman; G Tydén
Randomized double-blind study of liposomal amphotericin B (Ambisome) prophylaxis of invasive fungal infections in bone marrow transplant recipients.
Bone marrow transplantation 1993;12(6):577-82.
1993: S Klaesson; Olle Ringdén; L Markling; Mats Remberger; Inger Lundkvist
Immune modulatory effects of immunoglobulins on cell-mediated immune responses in vitro.
Scandinavian journal of immunology 1993;38(5):477-84.
1993: Olle Ringdén
Management of graft-versus-host disease.
European journal of haematology 1993;51(1):1-12.
1993: Johan Aschan; Olle Ringdén; B Sundberg; S Klaesson; Per Ljungman; B Lönnqvist
Increased risk of relapse in patients with chronic myelogenous leukemia given T-cell depleted marrow compared to methotrexate combined with cyclosporin or monotherapy for the prevention of graft-versus-host disease.
European journal of haematology 1993;50(5):269-74.
1993: Olle Ringdén; J Tollemar
Liposomal amphotericin B (AmBisome) treatment of invasive fungal infections in immunocompromised children.
Mycoses 1993;36(5-6):187-92.
1993: Sverker Ek; Olle Ringdén; L Markling; N Dahlberg; H Pschera; Ake Seiger; E Sundström; Magnus Westgren
Effects of cryopreservation on subsets of fetal liver cells.
Bone marrow transplantation 1993;11(5):395-8.
1993: J Tollemar; Olle Ringdén; S Andersson; B Sundberg; Per Ljungman; E Sparrelid; Gunnar Tydén
Prophylactic use of liposomal amphotericin B (AmBisome) against fungal infections: a randomized trial in bone marrow transplant recipients.
Transplantation proceedings 1993;25(1 Pt 2):1495-7.
1993: Olle Ringdén
Decreased transplant-related complications and improved leukemia-free survival in adults receiving methotrexate combined with cyclosporin compared with either agent alone for prevention of graft-versus-host disease. Advisory Committee of the International Bone Marrow Transplant Registry.
Transplantation proceedings 1993;25(1 Pt 2):1241-2.
1993: Sverker Ek; Olle Ringdén; L Markling; Magnus Westgren
Cryopreservation of fetal stem cells.
Bone marrow transplantation 1993;11 Suppl 1():123.
1993: Per Ljungman; Johan Aschan; J N Azinge; L Brandt; A Ehrnst; V Hammarström; S Klaesson; A Linde; B Lönnqvist; Olle Ringdén
Cytomegalovirus viraemia and specific T-helper cell responses as predictors of disease after allogeneic marrow transplantation.
British journal of haematology 1993;83(1):118-24.
1992: J Tollemar; S Andersson; Olle Ringdén; G Tydén
A retrospective clinical comparison between antifungal treatment with liposomal amphotericin B (AmBisome) and conventional amphotericin B in transplant recipients.
Mycoses 1992;35(9-10):215-20.
1992: Olle Ringdén; L Wennberg; Bo-Göran Ericzon; R Kallman; M Aström; Frans Duraj; Gunnar Söderdahl; Gunnar Tydén; Carl G Groth
Alteplase for hepatic veno-occlusive disease after bone marrow transplantation.
Lancet 1992;340(8818):546-7.
1992: P Pihlstedt; T Paulin; B Sundberg; B Nilsson; Olle Ringdén
Blood transfusion in marrow graft recipients.
Annals of hematology 1992;65(2):66-70.
1992: T Mattsson; A Heimdahl; Göran Dahllöf; B Lönnquist; Olle Ringdén
Oral and nutritional status in allogeneic marrow recipients treated with T-cell depletion or cyclosporine combined with methotrexate to prevent graft-versus-host disease.
Oral surgery, oral medicine, and oral pathology 1992;74(1):34-40.
1992: Olle Ringdén
Correlation of pretransplant viral serology and complications of bone marrow transplantation.
Annals of hematology 1992;64 Suppl():A143-7.
1992: Magnus Westgren; T M Bui; Sverker Ek; N Egberg; L Hagenfelt; L Markling; H Pschera; Ake Seiger; Olle Ringdén
[Intrauterine transplantation with fetal stem cells cures fetal diseases].
Läkartidningen 1992;89(19):1645, 1651.
1992: J Tollemar; B Sundberg; L Markling; Olle Ringdén
Immune response to Candida before and 5 years after allogeneic bone marrow transplantation.
Transplantation proceedings 1992;24(1):378-9.
1992: L Boström; Olle Ringdén
No association between splenomegaly and acute graft-vs.-host disease in humans after allogeneic bone marrow transplantation.
Transplantation proceedings 1992;24(1):374-5.
1992: A Tibell; Olle Ringdén; B Sundberg
Cyclosporine A in fat emulsion carrier: immunosuppressive effect in vitro.
Scandinavian journal of immunology 1992;35(2):231-6.
1992: L Boström; Olle Ringdén; M Forsgren
Strong donor mononuclear cell reactivity for herpes simplex virus antigen in immune donor/recipient pairs is associated with acute graft-versus-host disease.
Transplantation proceedings 1992;24(1):376-7.
1992: Olle Ringdén
Allogeneic bone marrow transplantation: the Huddinge experience.
Transplantation proceedings 1992;24(1):371-3.
1992: T Mattsson; Kristina Arvidson; A Heimdahl; Per Ljungman; G Dahllof; Olle Ringdén
Alterations in taste acuity associated with allogeneic bone marrow transplantation.
Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology 1992;21(1):33-7.
1992: Olle Ringdén; S Klaesson; B Sundberg; Per Ljungman; B Lönnqvist; U Persson
Decreased incidence of graft-versus-host disease and improved survival with methotrexate combined with cyclosporin compared with monotherapy in recipients of bone marrow from donors other than HLA identical siblings.
Bone marrow transplantation 1992;9(1):19-25.
1992: T Mattsson; Karl-Gösta Sundqvist; A Heimdahl; Göran Dahllöf; Per Ljungman; Olle Ringdén
A comparative immunological analysis of the oral mucosa in chronic graft-versus-host disease and oral lichen planus.
Archives of oral biology 1992;37(7):539-47.
1992: Johan Aschan; Olle Ringdén; Per Ljungman; B Lönnqvist; S Ohlman
Foscarnet for treatment of cytomegalovirus infections in bone marrow transplant recipients.
Scandinavian journal of infectious diseases 1992;24(2):143-50.
1991: Frans Duraj; L Bäckman; F Dati; Olle Ringdén
Serum levels of alpha-1 microglobulin and beta-2 microglobulin in bone marrow transplant recipients treated with cyclosporin A.
Transplant international : official journal of the European Society for Organ Transplantation 1991;4(3):146-50.
1991: L Boström; Olle Ringdén; M Forsgren
Strong donor mononuclear cell reactivity for herpes simplex virus (HSV) antigen in HSV immune donors combined with recipient seropositivity for HSV is associated with acute graft-versus-host disease.
Scandinavian journal of immunology 1991;34(1):45-52.
1991: Per Ljungman; Johan Aschan; P Bolme; R Lindqvist; B Lönnqvist; Olle Ringdén; Jacek Winiarski; G Gahrton
[Bone marrow transplantation or antithymocyte globulin in aplastic anemia? Both therapeutic alternatives result in good quality of life].
Läkartidningen 1991;88(25):2308-11.
1991: Christina Brattström; J Tollemar; Olle Ringdén; K Bergström; Gunnar Tydén
Isoamylase levels in bone marrow transplant patients are affected by total body irradiation and not by graft-versus-host disease.
Transplant international : official journal of the European Society for Organ Transplantation 1991;4(2):96-8.
1991: T Mattsson; A Heimdahl; G Dahllof; B Nilsson; B Lonnqvist; Olle Ringdén
Variables predicting oral mucosal lesions in allogenic bone marrow recipients.
Head & neck 1991;13(3):224-9.
1991: J Tollemar; Olle Ringdén
Early recovery of lymphocyte response to Candida after bone marrow transplantation in colonized patients.
Bone marrow transplantation 1991;7(4):285-91.
1991: Olle Ringdén; P Pihlstedt; L Markling; Johan Aschan; I Båryd; Per Ljungman; B Lönnqvist; J Tollemar; G Janossy; B Sundberg
Prevention of graft-versus-host disease with T cell depletion or cyclosporin and methotrexate. A randomized trial in adult leukemic marrow recipients.
Bone marrow transplantation 1991;7(3):221-6.
1991: Johan Aschan; Olle Ringdén; B Sundberg; G Gahrton; Per Ljungman; Jacek Winiarski
Methotrexate combined with cyclosporin A decreases graft-versus-host disease, but increases leukemic relapse compared to monotherapy.
Bone marrow transplantation 1991;7(2):113-9.
1991: Göran Dahllöf; Carl-Magnus Forsberg; M Näsman; T Mattsson; Thomas Modéer; B Borgström; P Bolme; Olle Ringdén
Craniofacial growth in bone marrow transplant recipients treated with growth hormone after total body irradiation.
Scandinavian journal of dental research 1991;99(1):44-7.
1991: J Tollemar; B Sundberg; L Markling; Olle Ringdén
Immunological response in vitro by Candida after allogeneic bone marrow transplantation.
Bone marrow transplantation 1991;7 Suppl 2():48.
1990: M R Abedi; Lennart Hammarström; Olle Ringdén; C I Edvard Smith
Development of IgA deficiency after bone marrow transplantation. The influence of acute and chronic graft-versus-host disease.
Transplantation 1990;50(3):415-21.
1990: M R Abedi; L Bäckman; L Boström; B Lindbäck; Olle Ringdén
Markedly increased serum erythropoietin levels following conditioning for allogeneic bone marrow transplantation.
Bone marrow transplantation 1990;6(2):121-6.
1990: Per Ljungman; M Wiklund-Hammarsten; V Duraj; Lennart Hammarström; B Lönnqvist; T Paulin; Olle Ringdén; M S Pepe; Gösta Gahrton
Response to tetanus toxoid immunization after allogeneic bone marrow transplantation.
The Journal of infectious diseases 1990;162(2):496-500.
1990: J Tollemar; Bo-Göran Ericzon; Lisbeth Barkholt; J Andersson; Olle Ringdén; Carl G Groth
Risk factors for deep candida infections in liver transplant recipients.
Transplantation proceedings 1990;22(4):1826-7.
1990: T Mattsson; A Heimdahl; Göran Dahllöf; B Lönnquist; Olle Ringdén
Predisposing factors for development of oral lesions after allogeneic bone marrow transplantation.
Transplantation proceedings 1990;22(1):210.
1990: J Tollemar; Olle Ringdén; Johan Aschan; B Sundberg
Which bone marrow transplant recipients are at risk of acquiring life-threatening fungal infections?
Transplantation proceedings 1990;22(1):208-9.
1990: M R Abedi; L Bäckman; L Boström; B Lindbäck; Olle Ringdén
Serum erythropoietin levels after bone marrow transplantation.
Transplantation proceedings 1990;22(1):205.
1990: Olle Ringdén; Carl G Groth; Johan Aschan; P Bolme; Per Ljungman; B Lönnqvist; Gunilla Malm; J E Månsson; Agneta Shanwell; L Svennerholm
Bone marrow transplantation for metabolic disorders at Huddinge Hospital.
Transplantation proceedings 1990;22(1):198-202.
1990: Johan Aschan; Olle Ringdén; J Tollemar; Per Ljungman; B Lönnqvist; P Pihlstedt; L Markling; B Sundberg
Improved survival in marrow recipients above 30 years of age with better prevention of graft-versus-host disease.
Transplantation proceedings 1990;22(1):195-7.
1990: Frans Duraj; L Bäckman; F Dati; Olle Ringdén
Monitoring low molecular weight serum proteins in cyclosporine A-treated bone marrow transplant recipients.
Transplantation proceedings 1990;22(1):203-4.
1990: Olle Ringdén; Johan Aschan; L Boström; G Dahllöf; J Tollemar; T Paulin; G Gahrton; Carl G Groth; S Klaesson; R Lindquist
Allogeneic bone marrow transplantations at Huddinge Hospital and strategies to improve survival.
Clinical transplants 1990;():175-87.
1989: A Heimdahl; T Mattsson; Göran Dahllöf; B Lönnquist; Olle Ringdén
The oral cavity as a port of entry for early infections in patients treated with bone marrow transplantation.
Oral surgery, oral medicine, and oral pathology 1989;68(6):711-6.
1989: M A Laurenzi; Mats A A Persson; C J Dalsgaard; Olle Ringdén
Stimulation of human B lymphocyte differentiation by the neuropeptides substance P and neurokinin A.
Scandinavian journal of immunology 1989;30(6):695-701.
1989: Göran Dahllöf; Carl-Magnus Forsberg; Olle Ringdén; P Bolme; B Borgström; M Näsman; A Heimdahl; Thomas Modéer
Facial growth and morphology in long-term survivors after bone marrow transplantation.
European journal of orthodontics 1989;11(4):332-40.
1989: J Tollemar; Olle Ringdén; L Boström; B Nilsson; B Sundberg
Variables predicting deep fungal infections in bone marrow transplant recipients.
Bone marrow transplantation 1989;4(6):635-41.
1989: J Tollemar; Olle Ringdén; K Holmberg
Candida albicans: mannan and protein activation of cells from various human lymphoid organs.
Scandinavian journal of immunology 1989;30(4):473-80.
1989: L Boström; Olle Ringdén; B Sundberg; Per Ljungman; A Linde; B Nilsson
Pretransplant herpes virus serology and chronic graft-versus-host disease.
Bone marrow transplantation 1989;4(5):547-52.
1989: Göran Dahllöf; A Heimdahl; Thomas Modéer; Svante Twetman; P Bolme; Olle Ringdén
Oral mucous membrane lesions in children treated with bone marrow transplantation.
Scandinavian journal of dental research 1989;97(3):268-77.
1989: M R Abedi; L Bäckman; U Persson; Olle Ringdén
Serum IgE levels after bone marrow transplantation.
Bone marrow transplantation 1989;4(3):255-60.
1989: Per Ljungman; E Fridell; B Lönnqvist; P Bolme; M Böttiger; Gösta Gahrton; A Linde; Olle Ringdén; B Wahren
Efficacy and safety of vaccination of marrow transplant recipients with a live attenuated measles, mumps, and rubella vaccine.
The Journal of infectious diseases 1989;159(4):610-5.
1989: L Bäckman; Olle Ringdén; F Dati
Serum levels of alpha-1 microglobulin in recipients of renal allografts.
Transplant international : official journal of the European Society for Organ Transplantation 1989;2(1):23-6.
1989: L Bäckman; EL Appelkvist; Olle Ringdén; Gustav Dallner
Urinary levels of basic glutathione transferase as an indicator of proximal tubular damage in renal transplant recipients.
Transplantation proceedings 1989;21(1 Pt 2):1514-6.
1989: J Tollemar; Olle Ringdén; L Bäckman; G Janossy; B Lönnqvist; L Markling; P Philstedt; B Sundberg
Results of four different protocols for prophylaxis against graft-versus-host disease.
Transplantation proceedings 1989;21(1 Pt 3):3008-10.
1989: Olle Ringdén; M M Horowitz
Graft-versus-leukemia reactions in humans. The Advisory Committee of the International Bone Marrow Transplant Registry.
Transplantation proceedings 1989;21(1 Pt 3):2989-92.
1989: Olle Ringdén
Immunodeficiency associated with bone marrow transplantation.
Current opinion in immunology 1989;1(3):497-501.
1989: Frans Duraj; L Bäckman; F Dati; Olle Ringdén
Serum alpha-1 microglobulin levels as indicators of renal function in allograft recipients.
Transplantation proceedings 1989;21(1 Pt 2):1871-2.
1989: L Bäckman; Olle Ringdén
The neopterin/creatinine ratio cannot be used to diagnose rejection episodes in renal transplant recipients.
Nephron 1989;53(3):287.
1989: Olle Ringdén; P Bolme; B Lönnqvist; Göran Gustafsson; A Kreuger
Allogeneic bone marrow transplantation versus chemotherapy in children with acute leukemia in Sweden.
Pediatric hematology and oncology 1989;6(2):137-44.
1989: Johan Aschan; Olle Ringdén; Per Ljungman; J Andersson; Ilona Lewensohn-Fuchs; M Forsgren
Influenza B in transplant patients.
Scandinavian journal of infectious diseases 1989;21(3):349-50.
1989: J Tollemar; K Holmberg; Olle Ringdén; B Lönnqvist
Surveillance tests for the diagnosis of invasive fungal infections in bone marrow transplant recipients.
Scandinavian journal of infectious diseases 1989;21(2):205-12.
1988: C I Edvard Smith; R Norberg; D Isenberg; N A Staines; Gösta Gahrton; Olle Ringdén; Lennart Hammarström
Anti-DNA antibody synthesis after bone marrow transplantation: implications for IgG subclass restrictivity and pathogenicity of autoantibodies.
Bone marrow transplantation 1988;3(6):583-8.
1988: L Boström; Olle Ringdén; B Sundberg; A Linde; J Tollemar; B Nilsson
Pretransplant herpesvirus serology and acute graft-versus-host disease.
Transplantation 1988;46(4):548-52.
1988: L Bäckman; Olle Ringdén; J Tollemar; B Lönnqvist
An increased risk of relapse in cyclosporin-treated compared with methotrexate-treated patients: long-term follow-up of a randomized trial.
Bone marrow transplantation 1988;3(5):463-71.
1988: T Paulin; Olle Ringdén; R Wahren
Cytomegalovirus-infected adherent cells interact synergistically and antagonistically with Staphylococcus aureus protein A in vitro.
Scandinavian journal of immunology 1988;28(2):177-84.
1988: Olle Ringdén; Carl G Groth; A Erikson; L Bäckman; S Granqvist; J E Månsson; L Svennerholm
Long-term follow-up of the first successful bone marrow transplantation in Gaucher disease.
Transplantation 1988;46(1):66-70.
1988: Olle Ringdén; B Sundberg; B Lönnqvist; J Tollemar; Gösta Gahrton; B Nilsson
Allogeneic bone marrow transplantation for leukemia: factors of importance for long-term survival and relapse.
Bone marrow transplantation 1988;3(4):281-90.
1988: J Tollemar; Olle Ringdén; B Sundberg; P Bolme; Christina Brattström; G Gahrton; L Johansen; B Lönnqvist
Decreased incidence of graft-versus-host disease in bone marrow transplantation recipients treated with a combination of cyclosporine and methotrexate.
Transplantation proceedings 1988;20(3):494-8.
1988: J Tollemar; Olle Ringdén; A Heimdahl; B Lönnqvist; B Sundberg
Decreased incidence and severity of graft-versus-host disease in HLA matched and mismatched marrow recipients of cyclosporine and methotrexate.
Transplantation proceedings 1988;20(3 Suppl 3):470-9.
1988: J Tollemar; Olle Ringdén; K Holmberg; B Lönnqvist
Serologic surveillance for evidence of deep disseminating fungal infections in bone marrow transplantation recipients.
Transplantation proceedings 1988;20(3):501-2.
1988: Olle Ringdén; P Bolme; B Lönnqvist; J Tollemar; B Borgström; G Dohlhöf; G Lundgren; Jacek Winiarski; G Gahrton; Carl G Groth
Allogeneic bone marrow transplantation in children at Huddinge Hospital.
Transplantation proceedings 1988;20(3):487-90.
1988: L Bäckman; EL Appelkvist; Olle Ringdén; Gustav Dallner
Appearance of basic glutathione transferase in the urine during tubular complications in renal transplant recipients.
Transplantation proceedings 1988;20(3):427-30.
1988: Olle Ringdén; L Markling; B Sundberg; J Tollemar
Spontaneous antibody secretion and DNA synthesis in blood lymphocytes increase during acute graft-versus-host disease.
Transplantation proceedings 1988;20(3):503-5.
1988: L Bäckman; EL Appelkvist; Olle Ringdén; Gustav Dallner
Effects of cyclosporine A on hepatic protein synthesis.
Transplantation proceedings 1988;20(3 Suppl 3):853-8.
1988: L Bäckman; Olle Ringdén; I Björkhem
Monitoring of serum beta 2 microglobulin and neopterin levels in renal transplant recipients: increased values during impaired renal function and cytomegalovirus infection.
Transplantation proceedings 1988;20(3):410-2.
1988: L Bäckman; I Brandt; G Dallner; Olle Ringdén
Tissue distribution of [3H]cyclosporine A in mice.
Transplantation proceedings 1988;20(2 Suppl 2):684-91.
1987: Olle Ringdén; B Sundberg; L Markling; J Tollemar
Polyclonal antibody secretion during acute graft-versus-host disease.
Scandinavian journal of immunology 1987;26(5):469-76.
1987: Olle Ringdén; P Pihlstedt; L Volin; J Nikoskelainen; B Lönnqvist; P Ruutu; T Ruutu; A Toivanen; B Wahren
Failure to prevent cytomegalovirus infection by cytomegalovirus hyperimmune plasma: a randomized trial by the Nordic Bone Marrow Transplantation Group.
Bone marrow transplantation 1987;2(3):299-305.
1987: Olle Ringdén
DNA synthesis in human blood mononuclear cells correlates with severity of acute graft-versus-host disease.
Bone marrow transplantation 1987;2(3):259-69.
1987: L Ost; B Lönnqvist; L Eriksson; Per Ljungman; Olle Ringdén
Hemorrhagic cystitis--a manifestation of graft versus host disease?
Bone marrow transplantation 1987;2(1):19-25.
1987: T Paulin; Olle Ringdén; B Nilsson
Immunological recovery after bone marrow transplantation: role of age, graft-versus-host disease, prednisolone treatment and infections.
Bone marrow transplantation 1987;1(3):317-28.
1987: Carl G Groth; I Fehrman; Olle Ringdén; G Lundgren
Related donor kidney transplantation is the best form of treatment for uremia.
Transplantation proceedings 1987;19(1 Pt 3):2278-9.
1986: Per Ljungman; H Wilczek; Gösta Gahrton; A Gustavsson; G Lundgren; B Lönnqvist; Olle Ringdén; B Wahren
Long-term acyclovir prophylaxis in bone marrow transplant recipients and lymphocyte proliferation responses to herpes virus antigens in vitro.
Bone marrow transplantation 1986;1(2):185-92.
1986: Olle Ringdén; T Paulin; V A Sundqvist; Britta Wahren; P Pihlstedt
Induction of immunoglobulin secretion and DNA synthesis in human lymphocytes in vitro by cytomegalovirus preparations.
Scandinavian journal of immunology 1986;24(3):273-81.
1986: Olle Ringdén; L Bäckman; B Lönnqvist; A Heimdahl; A Lindholm; P Bolme; G Gahrton
A randomized trial comparing use of cyclosporin and methotrexate for graft-versus-host disease prophylaxis in bone marrow transplant recipients with haematological malignancies.
Bone marrow transplantation 1986;1(1):41-51.
1984: Olle Ringdén; T Paulin; P Pihlstedt; B Lönnqvist; Britta Wahren
Cytomegalovirus antibody screening of blood donors for immunocompromised seronegative patients.
Lancet 1984;2(8410):1044.
1982: Olle Ringdén; B Lönnqvist; G Lundgren; G Gahrton; C G Groth; E Möller; I Båryd; B Johansson; P Pihlstedt; B Gullbring
Experience with a cooperative bone marrow transplantation program in Stockholm.
Transplantation 1982;33(5):500-4.
1980: T Kunori; Olle Ringdén
Antibody secretion and DNA synthesis induced by lipopolysaccharide in enriched human lymphocyte subpopulations.
Scandinavian journal of immunology 1980;11(2):137-45.
1980: Olle Ringdén
Activation of human T and B cells by rabbit anti-human beta 2-microglobulin.
Scandinavian journal of immunology 1980;11(2):121-30.